Tag Archives: SAMR

Registered Capital in China 2026: Subscription Deadlines, Capital Reduction and the New Registration Paperwork

  • The 2026 versions of the registration document and submission-material standards, in force since 1 May 2026, add specific paperwork for two new Company Law scenarios: capital-reduction registration where shareholders lose their rights for failing to contribute, and capital reduction to offset accumulated losses.
    2026 年 5 月 1 日起施行的《经营主体登记文书规范(2026 年版)》和《经营主体登记提交材料规范(2026 年版)》,为两类新《公司法》场景补充了登记材料:股东失权后的注册资本变更登记、弥补亏损的减少注册资本变更登记。
  • Foreign-invested LLCs and joint-stock companies established after July 2024 must pay up subscribed capital within five years; pre-existing companies whose remaining subscription terms exceed five years from 1 July 2027 must adjust those terms to within five years by 30 June 2027.
    2024 年 7 月后设立的外商投资有限公司和股份公司须在五年内缴足认缴出资;存量公司剩余认缴期限自 2027 年 7 月 1 日起超过五年的,须在 2027 年 6 月 30 日前将剩余期限调整至五年以内。
  • The registration materials now capture the shareholders’ subscription-term information directly, and the standards mandate real-name verification forms to curb false and impersonation registrations.
    新版登记材料直接采集股东出资期限信息,并要求实名登记确认表,防范虚假冒名登记。
  • Capital may be contributed in cash, in-kind assets, IP, land-use rights, equity, claims, and — where the law so provides — data and virtual-property rights, subject to proper valuation.
    出资方式包括货币、实物、知识产权、土地使用权、股权、债权等可用货币估价并可依法转让的非货币财产,法律有规定的,数据、网络虚拟财产也可作价出资,但须依法评估作价。
  • For FIEs, the practical agenda is a capital-structure health check: verify subscription terms against the 2027 adjustment deadline, review whether any shareholder’s unpaid rights are at risk of forfeiture, and prepare the new-format documents before any capital change.
    对外资企业的实操议程是一次资本结构体检:对照 2027 年调整期限核验认缴期限、排查股东未实缴权利是否面临失权风险,并在任何资本变动前备好新版文书。

Registered Capital in China 2026: Subscription Deadlines, Capital Reduction and the New Registration Paperwork | 2026 年中国注册资本实务:认缴期限、减资与新版登记文书

Overview

The revised Company Law, effective July 2024, rebuilt China’s registered-capital framework around a simple proposition: what you subscribe, you must pay up — within five years. Two years into the new regime, 2026 is the compliance inflection point. The 2026 versions of the registration document and submission-material standards (《经营主体登记文书规范(2026 年版)》 and 《经营主体登记提交材料规范(2026 年版)》, effective 1 May 2026) operationalise the new rules at the registry level: they add paperwork for shareholder-right forfeiture and loss-offsetting capital reductions, capture subscription-term information directly, and tighten real-name verification. For foreign-invested enterprises, whose capital structures often combine offshore parents, hybrid contributions and multi-entity groups, the 2026 paperwork is a reminder that capital compliance is a rolling obligation, not a one-time registration event.

The five-year subscription rule and the 2027 transition deadline

Under the revised Company Law and the State Council’s implementing regulation on registered-capital registration management, shareholders of limited liability companies must pay up their subscribed capital within five years of company establishment. For joint-stock companies, promoters must pay in full before incorporation. Companies established before 30 June 2024 — a category that includes most existing foreign-invested enterprises — are subject to a transition rule: if their remaining subscription terms would exceed five years measured from 1 July 2027, they must adjust those terms to within five years and record the change in the articles of association by 30 June 2027.

The practical significance for FIEs is the calendar. The 30 June 2027 deadline is now less than a year away for pre-July-2024 entities. A WFOE founded in 2019 with a 30-year subscription schedule under its old articles — a structure that was routine in the pre-2024 era — must either bring its payment schedule inside the window, complete a capital reduction, or face the consequences of non-compliance: default interest to other shareholders, damages, administrative penalties, and ultimately the risk that unpaid rights are forfeited.

Shareholder-right forfeiture and loss-offsetting reductions

The new Company Law introduced two mechanisms that the 2026 registration materials now support. The first is forfeiture of rights for non-contributing shareholders: where a shareholder fails to pay up by the deadline, the company may, after issuing a written demand and allowing a grace period, forfeit the unpaid portion of that shareholder’s rights, record the forfeiture, and complete a capital-reduction (or transfer) registration within six months. The 2026 material standards add the specific documents for “capital-change registration due to shareholder forfeiture,” giving registries a uniform processing basis.

The second is loss-offsetting capital reduction. Where a company has accumulated losses, it may reduce capital to offset them — a technique that is particularly relevant to foreign-invested enterprises with historical losses in China operations. The 2026 standards add the documents for “capital reduction to offset accumulated losses,” which differ from ordinary reduction filings. Companies should note that loss-offsetting reductions do not follow the same creditor-notice and protection procedures as ordinary reductions in all respects, and the new paperwork reflects the regime’s attempt to standardise what was previously handled ad hoc.

Contribution methods and valuation

The registration rules confirm a broad menu of contribution methods: cash, in-kind assets, intellectual property, land-use rights, equity and claims, provided they can be valued in monetary terms and transferred lawfully. The Company Registration Administrative Implementation Measures add that, where law provides for it, data and network virtual-property rights can also be contributed as capital. Non-monetary contributions must be appraised to prevent over- or under-valuation.

For foreign-invested enterprises, the recurring issues are: cross-border valuation consistency (how an offshore group values IP contributed to a Chinese subsidiary), the interaction between contribution methods and foreign-exchange registration (capital injection verification applies to cash flows), and the record-keeping duty — the company must maintain valuation reports and contribution records for inspection. The 2026 standards also require real-name verification forms that record the applicant’s identity and the transaction’s consistency, a measure aimed squarely at false and impersonation registrations.

Practical checklist for FIEs

  1. Run a subscription-schedule audit. List every FIE entity, its establishment date, subscription terms and paid-in status, and flag entities whose remaining terms exceed five years from 1 July 2027.
  2. Decide the transition strategy by mid-2027. For each flagged entity, choose among adjusting the schedule to five years, completing the capital injection, or executing a capital reduction — and record the change in the articles of association before 30 June 2027.
  3. Address non-contributing shareholders early. Where a shareholder is unwilling or unable to pay, follow the demand-and-grace procedure, and if forfeiture is triggered, complete the capital-change registration within six months using the new-format documents.
  4. Prepare loss-offsetting reduction documentation. For entities with accumulated losses, assess whether a loss-offsetting capital reduction is appropriate and prepare the new-format filing package.
  5. Refresh governance documents. Update articles of association, shareholder contribution records and valuation reports, and confirm that board resolutions supporting any capital change follow the new Company Law’s quorum and procedure rules.

Related reading

  • The revised Company Law (effective July 2024) and the State Council’s regulation on registered-capital registration management.
  • The Company Registration Administrative Implementation Measures (2025), which detail contribution methods and the 2027 transition rule.
  • SAMR’s 2026 registration document and material standards, which codify the new paperwork.

Sources

  • 武汉市洪山区人民政府《市场监管总局关于印发经营主体登记文书规范和提交材料规范(2026 年版)的通知》: https://www.hongshan.gov.cn/gzfw/ztfw/qykb_85388/zctz_85390/202608/t20260825_2838574.shtml
  • 如东县人民政府《公司登记管理实施办法》: https://www.rudong.gov.cn/qxzdfzfz1fz/bmwj/content/8aefc77b-a10e-4f5b-a037-e6bfd0461789.html
  • 国家市场监督管理总局《关于进一步优化政务服务提升行政效能推进”高效办成一件事”的实施意见》: https://www.samr.gov.cn/djzcj/zcfg/qt/art/2026/art_88cdbfde20d54e9396ff6d7d649b6acd.html
  • 洞口县商务局《外商投资办事指南》(外资登记流程): https://www.dongkou.gov.cn/dongkou/tzgg/202608/fd4c261c8deb48baa48e8cef772dbcd4.shtml

2026 年中国注册资本实务:认缴期限、减资与新版登记文书

概述

2024 年 7 月施行的新《公司法》围绕一个简单命题重建了中国注册资本制度:认缴即须实缴——五年之内。新制度实施两年后,2026 年成为合规拐点。2026 年 5 月 1 日起施行的《经营主体登记文书规范(2026 年版)》和《经营主体登记提交材料规范(2026 年版)》,在登记机关层面把新规则落地:补充股东失权与弥补亏损减资的登记材料、直接采集出资期限信息、收紧实名验证。对外资企业而言——其资本结构往往叠加离岸母公司、混合出资和多实体集团——2026 年新版文书提醒:资本合规是滚动义务,而非一次性登记事件。

五年认缴规则与 2027 年过渡期

依据新《公司法》和国务院注册资本登记管理制度规定,有限责任公司股东须在公司成立之日起五年内缴足认缴出资。股份有限公司发起人须在公司成立前全额缴纳股款。2024 年 6 月 30 日前设立的存量公司——涵盖绝大多数既有外资企业——适用过渡规则:剩余认缴出资期限自 2027 年 7 月 1 日起超过五年的,须在 2027 年 6 月 30 日前将剩余期限调整至五年以内,并记载于公司章程。

对外资企业而言,实质意义在于日历。2027 年 6 月 30 日截止日距今已不足一年。2019 年设立、按旧章程约定 30 年认缴期的外商独资企业——这在 2024 年前是常规结构——要么把缴付安排纳入窗口期内,要么完成减资,否则将面临后果:对其他股东承担逾期利息与赔偿、行政处罚,最终是未实缴权利被失权的风险。

股东失权与弥补亏损减资

新《公司法》引入的两项机制,现在有了 2026 版登记材料支撑。其一是股东失权:股东未按期缴足的,公司经书面催缴并给予宽限期后,可失权该股东未实缴部分的权利,记载失权事项,并在六个月内办理减资(或转让)登记。2026 版材料规范补充了”因股东失权办理注册资本变更登记”的具体文书,给登记机关统一的办理依据。

其二是弥补亏损的减资。公司存在累计亏损的,可减资弥补亏损——这一技术对在华运营存在历史亏损的外资企业尤为相关。2026 版材料规范新增”弥补亏损减少注册资本变更登记”文书,与普通减资申报相区分。企业应注意,弥补亏损减资并非在所有方面都遵循与普通减资相同的债权人通知与保护程序,新版文书反映了监管层对这一此前个案化处理事项的标准化尝试。

出资方式与评估作价

登记规则确认了宽泛的出资方式菜单:货币、实物、知识产权、土地使用权、股权、债权等可以用货币估价并可以依法转让的非货币财产。《公司登记管理实施办法》进一步明确,法律对数据、网络虚拟财产权属有规定的,数据、网络虚拟财产也可作价出资。非货币出资须依法评估作价,不得高估或低估。

外资企业反复遇到的问题包括:跨境估值一致性(离岸集团向中国子公司投入知识产权时如何估值)、出资方式与外汇登记的衔接(资本金验资适用于现金流动),以及留档义务——公司须保存评估报告与出资记录备查。2026 版文书还要求实名登记确认表,记录申请人身份确认与登记业务关联性、一致性情况,直指虚假冒名登记。

外资企业实操清单

  1. 开展认缴期限审计。列出每家境内外资主体、设立日期、认缴期限与实缴状态,标记剩余期限自 2027 年 7 月 1 日起超过五年的实体。
  2. 在 2027 年年中前确定过渡策略。对每家境内外资实体,在”调整至五年、完成注资、执行减资”三项中选择,并在 2027 年 6 月 30 日前将变更记载于章程。
  3. 尽早处理未实缴股东。股东不愿或无力缴付的,按催缴加宽限期程序推进;触发失权的,用新版文书在六个月内完成资本变更登记。
  4. 备好弥补亏损减资文件。对存在累计亏损的实体,评估是否适合做弥补亏损减资,并准备新版申报包。
  5. 刷新治理文件。更新章程、股东出资记录与评估报告,确认支持资本变动的董事会决议符合新《公司法》的议事规则与程序要求。

相关阅读

  • 《公司法》(2024 年 7 月施行)与国务院注册资本登记管理制度规定。
  • 《公司登记管理实施办法》(2025 年),详述出资方式与 2027 年过渡规则。
  • 市场监管总局 2026 版登记文书与材料规范,固化新版文书。

来源

  • 武汉市洪山区人民政府《市场监管总局关于印发经营主体登记文书规范和提交材料规范(2026 年版)的通知》:https://www.hongshan.gov.cn/gzfw/ztfw/qykb_85388/zctz_85390/202608/t20260825_2838574.shtml
  • 如东县人民政府《公司登记管理实施办法》:https://www.rudong.gov.cn/qxzdfzfz1fz/bmwj/content/8aefc77b-a10e-4f5b-a037-e6bfd0461789.html
  • 国家市场监督管理总局《关于进一步优化政务服务提升行政效能推进”高效办成一件事”的实施意见》:https://www.samr.gov.cn/djzcj/zcfg/qt/art/2026/art_88cdbfde20d54e9396ff6d7d649b6acd.html
  • 洞口县商务局《外商投资办事指南》(外资登记流程):https://www.dongkou.gov.cn/dongkou/tzgg/202608/fd4c261c8deb48baa48e8cef772dbcd4.shtml

Setting Up a WFOE in 2026: The Registration Track Is Now the Easy Part

  • China registered 35,000 new foreign-invested enterprises (FIEs) in H1 2026, up 7% year on year, with border provinces leading growth (Heilongjiang +79.5%, Inner Mongolia +29.1%, Guangxi +16.6%).
    2026 年上半年全国新设外商投资企业 3.5 万户、同比增长 7%,沿边省份领涨(黑龙江 +79.5%、内蒙古 +29.1%、广西 +16.6%)。
  • New FIE registrations from Belt and Road countries grew 19.3%, Arab countries 20.6% and African Union countries 42.8% (1.1 万户 combined), offsetting declines from the US (-10.7%), UK (-21.4%) and Japan (-34.9%).
    共建”一带一路”国家、阿拉伯国家、非盟国家在华新设企业分别增长 19.3%、20.6%、42.8%(合计 1.1 万户),对冲了美国(-10.7%)、英国(-21.4%)、日本(-34.9%)的下降。
  • Shandong and eight Yellow-River provinces now recognise foreign-investor qualification-certificate filings across the region: an investor that has filed in one province can skip repeat notarisation and legalisation when registering in another.
    山东省与沿黄八省实现外国(地区)投资者主体资格证明文件互通互认:投资者在任一省份备案后,到其他省份登记无需重复办理公证认证。
  • The SAMR’s 2026 edition of registration document and materials standards (in force since 1 May 2026) implements the new Company Law: itemised capital-contribution deadlines, shareholder registers, standardised real-name verification and migration registration as a single “one thing” procedure.
    市场监管总局《经营主体登记文书规范和提交材料规范(2026 年版)》(2026 年 5 月 1 日起施行)落实新《公司法》:出资期限逐笔载明、股东名册、规范实名登记确认,迁移登记并入”一件事”。
  • Registration is increasingly same-day: Turpan completed a Malaysian-invested company’s setup in one day in August 2026 through a “one window, one network, full assistance” model, with online steps taking two hours.
    登记越来越”当日办结”:2026 年 8 月吐鲁番以”一窗受理、一网通办、全程帮办”模式当日完成一家马来西亚投资企业设立,线上环节仅 2 小时。
  • For foreign investors, the practical takeaway is that setup friction has fallen sharply: cross-province reuse of qualification certificates, online submission with electronic signatures, and compressed timelines mean the registration step itself is rarely the bottleneck — preparation of apostilled originals and Chinese translations remains the critical path.
    对外国投资者,实操要点是设立摩擦已显著下降:资格证明跨省复用、在线提交与电子签名、时限压缩意味着登记环节本身很少再是瓶颈——加签原件与中文译本的准备仍是关键路径。

Setting Up a WFOE in 2026: The Registration Track Is Now the Easy Part | 2026 年设立外资企业:登记环节已成为轻松的部分

The H1 2026 picture

On 29 August 2026 the State Administration for Market Regulation (SAMR) published its H1 2026 data on foreign-invested enterprises: 35,000 new FIEs were registered in the first half, up 7% year on year. The composition tells an interesting story. By region, export provinces and border provinces grew in tandem — Hainan +38.6%, Shandong +15.2%, Guangdong +8.1% and Jiangsu +6.8% on the export side, and Heilongjiang +79.5%, Inner Mongolia +29.1%, Guangxi +16.6% and Jilin +12% along the border. By source country, Belt and Road, Arab and African Union countries registered 11,000 enterprises combined, growing 19.3%, 20.6% and 42.8% respectively, offsetting declines from the US (-10.7%), the UK (-21.4%) and Japan (-34.9%). By sector, the consumer market is pulling foreign capital: health and social work +27.1%, wholesale and retail +11.9%, and accommodation and catering +11.7%.

What is making registration easier

Behind the numbers, three reforms are cutting the friction of FIE setup. First, cross-province reuse of qualification certificates: Shandong and the eight Yellow-River provinces now recognise foreign-investor qualification-certificate filings across the region, so an investor that has already filed its notarised and legalised corporate documents in one province can skip repeat notarisation and legalisation when registering in another. Rizhao used exactly this mechanism in August 2026 for an inner-to-foreign conversion, accepting a certificate package filed two months earlier in Linyi and completing the registration without fresh legalisation. Second, the 2026 edition of the SAMR’s registration document and materials standards (in force since 1 May 2026): the new Company Law’s rules are now built into the forms — itemised capital-contribution deadlines, shareholder registers for capital increases and decreases, standardised real-name verification (with identity documents on separate pages to protect sensitive data), stronger agent-management requirements, and migration registration as a single procedure in which the destination authority directly pulls the file from the origin, removing the round trip. Third, same-day capability: Turpan completed a Malaysian-invested company’s setup in one day in August 2026 through a “one window, one network, full assistance” model — the online portion took two hours — and border cities like Heihe run a “rapid clearance plus licence” channel for foreign investors.

What has not changed: the documents

Despite the ease of the filing step itself, the document package remains the critical path. For a foreign investor setting up a WFOE, the essentials are: notarised and legalised (apostilled where the Hague Convention applies) certificates of the foreign investor — company registration certificate or passport pages for individuals — with Chinese translations; the articles of association; the investor’s bank reference; details of the legal representative, directors and supervisors; and a registered-address certificate. Since May 2026, foreign documents must be accompanied by both the Chinese translation and the foreign original, with the translator’s seal, accuracy statement and contact details. The good news from the inter-province recognition schemes is that this package is now prepared once and reused across a growing set of provinces.

Practical guidance for foreign investors

Foreign investors should sequence the setup as follows. (1) Prepare the certificate package first: notarisation, legalisation (or apostille) and Chinese translation of corporate documents is the longest lead-time item — start it before any other step. (2) Check the inter-province recognition schemes: if your group has already filed qualification certificates in one of the recognising provinces (Shandong and the Yellow-River eight), the package can be reused when registering elsewhere in the region, saving weeks and notarisation fees. (3) Use the online channels: name pre-approval, submission and real-name verification are handled through the local “one-window” platforms with electronic signatures; the physical visit is limited to presentation of originals where required. (4) Mind the new Company Law details: itemise the capital-contribution deadline on registration, prepare the shareholder register for capital changes, and note that real-name verification applies to shareholders, directors, supervisors, financial officers and the registration liaison. (5) Plan for the follow-on steps: after the business licence, the sequence is tax registration, chops, social insurance and pension fund accounts, bank account and FDI foreign-exchange registration — the registration itself is rarely the bottleneck any more.

Sources


2026 年设立外资企业:登记环节已成为轻松的部分

上半年数据图景

2026 年 8 月 29 日,市场监管总局公布上半年外商投资企业数据:上半年新设外商投资企业 3.5 万户,同比增长 7%。结构很有意思。按区域,出口大省与沿边省份”双轮驱动”——出口侧海南 +38.6%、山东 +15.2%、广东 +8.1%、江苏 +6.8%;沿边侧黑龙江 +79.5%、内蒙古 +29.1%、广西 +16.6%、吉林 +12%。按来源国,共建”一带一路”国家、阿拉伯国家、非盟国家合计新设企业 1.1 万户,分别增长 19.3%、20.6%、42.8%,对冲了美国(-10.7%)、英国(-21.4%)、日本(-34.9%)的下降。按领域,消费市场成为吸引外资新方向:卫生和社会工作 +27.1%、批发和零售业 +11.9%、住宿和餐饮业 +11.7%。

什么让登记变容易了

数据背后,三项改革正在降低外资企业设立的摩擦。其一,资格证明跨省复用:山东省与沿黄八省实现外国(地区)投资者主体资格证明文件互通互认,投资者在一省备案过公证认证的公司文件后,到另一省登记无需重复办理。日照 2026 年 8 月正用此机制办结一宗内资转外资——采信两月前在临沂备案的资格证明文件,免去重新认证。其二,登记规范 2026 年版(2026 年 5 月 1 日起施行):新《公司法》要求已写入表单——出资期限逐笔载明、增减资需股东名册、实名登记确认规范化(身份证件单独列页保护敏感信息)、代理机构管理强化,以及迁移登记”一件事”——由迁入地直接向迁出地调档,企业无需往返。其三,当日办结能力:2026 年 8 月吐鲁番以”一窗受理、一网通办、全程帮办”模式当日完成一家马来西亚投资企业设立,线上环节仅 2 小时;黑河等边境城市还为外国投资者开通”极速通关+办照”通道。

没变的是什么:材料

尽管申报环节本身已很顺畅,材料包仍是关键路径。外国投资者设立 WFOE 的必备材料是:经公证认证(海牙公约适用国为加签)的外国投资者主体资格证明——公司注册证书或自然人护照页——附中文翻译;公司章程;投资者资信证明;法定代表人、董事、监事信息;注册地址证明。自 2026 年 5 月起,外文材料须同时提交中文翻译件与外文原件,翻译件须加盖翻译单位公章、注明”翻译准确”及联系方式。跨省互认带来的好消息是:这套材料现在只需准备一次,可在越来越多的省份复用。

给外国投资者的实操建议

外国投资者应按如下顺序推进设立。(1)先备证书包:公司文件的公证、认证(或加签)与中文翻译是耗时最长的环节——应早于其他任何步骤启动。(2)核查跨省互认方案:若贵集团已在互认省份(山东及沿黄八省)备案过资格证明,在该区域其他省份登记时可复用,省去数周时间与公证费用。(3)走线上渠道:名称预核、申报与实名认证通过各地”一窗”平台电子签名完成,线下到访仅限于按需核验原件。(4)注意新《公司法》细节:登记时逐笔载明出资期限、资本变动备好股东名册,并注意实名认证适用于股东、董监高、财务负责人与登记联络员。(5)规划后续步骤:营业执照之后的顺序是税务登记、刻章、社保公积金开户、银行开户与 FDI 外汇登记——登记本身已很少是瓶颈。

Sources

Merger Review as an Anti-“Involution” Tool: The SAMR’s Six Typical Cases of 21 August 2026

  • On 21 August 2026 the State Administration for Market Regulation published six typical cases of concentration review aimed at curbing “involution-style” competition, spanning online audio, photovoltaics, energy storage, lithium-battery materials, auto parts and coal logistics.
    2026 年 8 月 21 日,市场监管总局公布六起经营者集中审查典型案例,聚焦整治”内卷式”竞争,覆盖在线音频、光伏、储能、锂电材料、汽车零部件与煤炭物流等领域。
  • Tencent’s acquisition of Ximalaya was approved with five conditions: the SAMR found the deal could exclude or restrict competition in China’s online-audio and online-music platform markets, and attached targeted remedies.
    腾讯收购喜马拉雅案被附加 5 项限制性条件批准:市场监管总局认定该集中对中国境内在线音频播放平台市场、网络音乐播放平台市场可能具有排除、限制竞争效果,依法附加针对性条件。
  • The other five deals were cleared unconditionally: TCL Zhonghuan’s acquisition of Yidao New Energy, Jingjiang Industrial’s acquisition of East Group, Cangzhou Mingzhu’s JV in lithium separators, Ningbo Huaxiang’s auto-parts JV and Tiangchi Energy’s logistics JV — all framed as consolidating capacity to escape low-end price wars.
    其余五起案件无条件批准:TCL 中环收购一道新能源、荆江实业收购易事特、沧州明珠锂电隔膜合营、宁波华翔汽车零部件合营、天池能源物流合营——均被定位为整合产能、摆脱低端价格战。
  • Delegated review is now routine in these cases: local bureaus (Beijing, Chongqing, Shanghai, Guangdong, Shaanxi, etc.) handled the case work under the SAMR’s delegation, with at least one deal cleared in 17 days.
    委托审查已成为这些案件的常规路径:北京、重庆、上海、广东、陕西等地市场监管部门受总局委托开展审查,其中一宗合营案仅用 17 天完成全流程审查。
  • For foreign companies, the signal is twofold: China’s merger control is being used proactively to reshape industry structure and police “involution”, and conditional approvals remain a live remedy — buyers should plan remedies into deal timelines where platform or market power is involved.
    对外国企业,信号有两层:中国经营者集中审查正被积极用于重塑行业结构、治理”内卷”;附条件批准仍是现行救济工具——涉平台或市场支配力交易时,买方应把救济条件纳入交易时间表筹划。

Merger Review as an Anti-“Involution” Tool: The SAMR’s Six Typical Cases of 21 August 2026 | 经营者集中审查作为治理”内卷”工具:市场监管总局 2026 年 8 月 21 日六起典型案例

The six cases at a glance

On 21 August 2026 the State Administration for Market Regulation published six typical cases from its 2026 concentration-review campaign, which it has framed as serving both quality improvement and competition protection. The cases span: Tencent Holdings’ acquisition of Ximalaya (online audio); TCL Zhonghuan’s acquisition of Yidao New Energy (photovoltaics); Jingjiang Industrial Investment Group’s acquisition of East Group (energy storage / AI plus new energy); Cangzhou Mingzhu’s new JV with an East-Guangzhou investment vehicle (lithium-battery separators and pipe materials); Ningbo Huaxiang Xinsandian’s JV with Zhejiang Anzhi Auto Technology (high-end suspension and air-spring auto parts); and Tiangchi Energy’s new logistics JV (coal supply-chain transport). Five were cleared unconditionally; one — Tencent/Ximalaya — was approved with conditions.

The conditional approval that matters

The Tencent/Ximalaya deal is the case with the most compliance-relevant detail. The transaction was filed on 11 June 2025 and accepted on 3 September 2025. After market investigation and analysis, the SAMR concluded that the concentration could have the effect of excluding or restricting competition in China’s online-audio platform market and online-music platform market. On 12 May 2026 it approved the deal subject to five conditions designed to address the identified competition concerns and stakeholder expectations — preserving the competitive structure of the online-audio and online-music markets, protecting the interests of undertakings and consumers, and guarding against platform anti-competitive conduct. The case shows that in platform-economy deals, conditional approval with behavioural remedies is a live, structural feature of Chinese merger control, not a theoretical possibility.

Why the other five were cleared

The five unconditional clearances share a logic: the transactions consolidate capacity in sectors where the regulator sees low-quality, homogenous “involution” as the main problem. TCL Zhonghuan acquiring Yidao New Energy integrates BC-cell technology and reduces inefficient supply in photovoltaics, pushing the sector from scale expansion to quality improvement. Jingjiang Industrial’s acquisition of East Group channels state capital and industrial platforms into transforming the target into an “AI plus new energy” services provider. Cangzhou Mingzhu’s JV strengthens regional lithium-battery-material supply; Ningbo Huaxiang’s JV focuses high-end auto parts and helps break dependence on external technology; and Tiangchi Energy’s JV vertically integrates coal production with logistics to secure outbound transport capacity. In each case the regulator’s analysis explicitly links the transaction to curing price wars and improving industry structure.

Delegated review as the operating model

A striking operational detail is the role of provincial bureaus. Under the SAMR’s delegation system, the case work was handled by local authorities: Beijing reviewed TCL Zhonghuan/Yidao (accepted 3 April, cleared 25 May), Chongqing handled Jingjiang/East Group (accepted 9 January, cleared 22 January), Shanghai handled the Ningbo Huaxiang JV, Guangdong the Cangzhou Mingzhu JV, and Shaanxi the Tiangchi Energy JV — with the Cangzhou deal completed in 17 days end to end. The message for deal teams is practical: delegation is now the default for many cases, so the relevant timetable and dialogue partner is often the provincial bureau, and streamlined simple-case processing can deliver genuinely fast clearances.

What foreign companies should take away

For foreign acquirers, the August package carries three lessons. First, policy intent: Chinese merger control is an active industrial-policy instrument — deals that consolidate capacity to exit “involution” are welcomed and cleared quickly, while deals that entrench market power face conditions. Second, remedy planning: in platform or market-power situations, conditional approval with behavioural remedies should be assumed possible; building remedy negotiation into the deal timeline, and structuring the transaction to address competition concerns early, reduces uncertainty. Third, process: expect provincial-bureau delegation and prepare filings accordingly — engage the right bureau, budget for delegated timelines, and use the streamlined track where the case qualifies as simple. The six cases are also a useful precedent library: the SAMR’s published reasoning shows how it weighs market definition, competitive effects and remedies in the sectors now subject to its “anti-involution” scrutiny. Deal teams should download and circulate the full text to their internal antitrust review checklists, since the reasoning style and the kinds of evidence the regulator cites are the best available guide to how future filings in these sectors will be assessed.

Sources


经营者集中审查作为治理”内卷”工具:市场监管总局 2026 年 8 月 21 日六起典型案例

六起案件一览

2026 年 8 月 21 日,市场监管总局公布 2026 年经营者集中反垄断监管效能提升专项行动的六起典型案例,覆盖:腾讯控股收购喜马拉雅股权案(在线音频);TCL 中环收购一道新能源股权案(光伏);湖北荆江实业投资集团收购易事特集团股权案(储能/”AI+新能源”);沧州明珠与广州增城东部中心新设合营企业案(锂电隔膜与管材);宁波华翔新三电与浙江安致汽车科技新设合营企业案(高端悬架与空气弹簧汽车零部件);新疆天池能源与新疆象道物流新设合营企业案(煤炭供应链物流)。其中五起无条件批准,一起——腾讯/喜马拉雅——附条件批准。

值得关注的附条件批准案

腾讯收购喜马拉雅案是合规信息量最大的一起。交易于 2025 年 6 月 11 日申报、9 月 3 日受理。经市场调查与分析,市场监管总局认定该集中对中国境内在线音频播放平台市场、网络音乐播放平台市场可能具有排除、限制竞争效果,于 2026 年 5 月 12 日附加 5 项限制性条件批准——条件直指竞争问题与各方关切,维护两个市场的公平竞争秩序,保障经营主体与消费者合法权益,防范平台反竞争行为。该案显示:平台经济交易中,附行为性救济条件的批准是中国经营者集中制度中现实、结构性的工具,而非理论可能。

其余五起为何无条件通过

五起无条件批准共享同一逻辑:交易整合了监管者眼中以低质同质”内卷”为主要问题的行业产能。TCL 中环收购一道新能源整合 BC 电池技术、减少光伏低效供给,推动行业从规模扩张转向质量提升。荆江实业收购易事特以国有资本与产业载体推动标的向”AI+新能源”综合服务商转型。沧州明珠合营强化区域锂电材料配套;宁波华翔合营聚焦高端汽车零部件、助力突破外部技术依赖;天池能源合营纵向整合煤炭生产与物流、保障出疆运力。每起案件中,监管分析都把交易与治理价格战、改善行业结构直接关联。

委托审查成为运营模式

一个引人注目的操作细节是省级部门的角色。在市场监管总局委托审查制度下,案件由地方部门承办:北京审查 TCL 中环/一道新能源(4 月 3 日受理、5 月 25 日批准),重庆承办荆江/易事特(1 月 9 日受理、1 月 22 日批准),上海承办宁波华翔合营,广东承办沧州明珠合营,陕西承办天池能源合营——沧州案全流程仅用 17 天。对交易团队的实操信息:委托已是许多案件的默认路径,相关时间表与对接方往往是省级部门,简化的简易案件处理可带来真正快速的批准。

外国企业应吸取什么

对外国收购方,8 月一揽子有三重启示。第一,政策意图:中国经营者集中审查是积极的产业政策工具——整合产能以退出”内卷”的交易受到欢迎并快速放行,而巩固市场支配力的交易将面临条件。第二,救济筹划:涉平台或市场支配力情形,应假设附行为性救济的条件批准可能发生;把救济谈判纳入交易时间表、尽早以交易结构回应竞争关切,可降低不确定性。第三,流程:预期省级委托并相应准备申报——对接正确部门、按委托时间表预算、符合简易条件的走简化通道。六起案例也是有用的先例库:总局公布的论证展示其在当前”反内卷”审视行业里如何权衡相关市场界定、竞争影响与救济。交易团队应下载并通读全文、并入内部反垄断审查清单——论证风格与监管引用的证据类型,是判断这些行业未来申报将如何被评估的最佳可得指南。

Sources

Product Standards, Testing & GB Compliance when Sourcing from China: a buyer’s checklist

  • China operates a dual-track standards system: mandatory national standards (强制性国家标准, “GB” without a slash) are legally binding, while recommended standards (推荐性, “GB/T”) are voluntary unless referenced by regulation or contract.
    中国实行双轨标准体系:强制性国家标准(不带斜杠的”GB”)具法律约束力,推荐性标准(”GB/T”)原则上自愿,但若被法规或合同引用则须执行。
  • A foreign buyer’s first job is to confirm which GB applies to the product, whether it is mandatory, and which version is currently in force — using the official National Public Service Platform for Standards (全国标准信息公共服务平台).
    外资买家的首要任务是确认产品适用哪项 GB、是否强制、现行版本为何——通过官方”全国标准信息公共服务平台”查询。
  • Product testing should be done by laboratories accredited under CNAS (中国合格评定国家认可委员会) and, for China-market release, by CMA-recognised inspection bodies (检验检测机构资质认定) — verify credentials on the national accreditation platform before relying on a report.
    产品检测应由 CNAS(中国合格评定国家认可委员会)认可的实验室,以及面向中国市场的 CMA(检验检测机构资质认定)机构完成——在依赖报告前于国家认可平台核验资质。
  • Beyond CCC (covered separately), many products face mandatory GB safety/EMC/energy or food-contact requirements; the 2026 SAMR drive tightened CCC supervision and pushed “same line, same standard, same quality” for domestic and export goods.
    除 CCC(另文专述)外,众多产品还须满足强制性 GB 安全/电磁兼容/能效或食品接触要求;2026 年市场监管总局强化 CCC 监管,并推进内外贸产品”同线同标同质”。
  • Counterfeit or non-representative test reports are a real risk — always match the laboratory’s scope (CNAS/CMA) to the exact standard and product, and keep the original, dated report in the file.
    虚假或不具代表性的检测报告是真实风险——务必将实验室的 CNAS/CMA 范围与确切标准及产品对应,并留存带日期的原件。
  • Build standards compliance into the supplier contract: specify the applicable GB version, require valid test reports, and define incoming-inspection and recall responsibilities.
    将标准合规写入供应商合同:明确适用 GB 版本、要求有效检测报告,并约定进货检验与召回责任。
  • For regulated sectors (food, cosmetics, medical devices, toys, electronics), layer GB compliance with the sector regulator’s filing/marketing-authorisation rules — standards are necessary but not sufficient.
    对食品、化妆品、医疗器械、玩具、电子等受监管行业,须将 GB 合规与行业主管部门的备案/上市许可规则叠加——标准合规是必要非充分条件。

Product Standards, Testing & GB Compliance when Sourcing from China: a buyer’s checklist | 在华采购的产品标准、检测与国标(GB)合规:买家清单

Overview

When a foreign buyer sources from China, price and lead time matter — but a product that fails to meet Chinese (or destination) standards can mean rejected shipments, recalls, fines, and reputational damage. Compulsory Product Certification (CCC) grabs the headlines, yet the broader landscape of national standards (GB), mandatory versus recommended status, and third-party testing is where many sourcing compliance gaps actually hide.

This guide gives foreign-invested enterprises and procurement teams a practical map of China’s standards and testing regime, the official query tools, and a due-diligence checklist — grounded in the Standardization Law, SAMR/CNCA rules, and CNAS accreditation.

China’s standards hierarchy

China’s technical standards form a hierarchy:

  • National standards (国家标准, “GB”): mandatory (强制性, “GB”) or recommended (推荐性, “GB/T”). Mandatory GB cover health, safety, environmental protection and fundamental matters and are legally binding.
  • Industry standards (行业标准), local standards (地方标准), and group/enterprise standards (团体/企业标准) sit below national ones and cannot lower mandatory requirements.

The key buyer takeaway: a product may need to conform to a mandatory GB before it can be sold in China or, in some cases, before it can be exported (where the destination references the Chinese standard). Always confirm the current, in-force version — standards are revised, and using a superseded version is a common compliance miss.

Finding the right standard

Use the official, free platforms to identify applicable standards:

  • National Public Service Platform for Standards Information (全国标准信息公共服务平台) — std.samr.gov.cn / www.samr.gov.cn: search mandatory and recommended national standards, see status (in force / to be abolished), and replacement relationships.
  • Full-text open GB system (国家标准全文公开系统) — free access to most GB texts.

When screening a supplier, ask for the specific GB numbers and versions the product is built to, and cross-check them against the platform. Beware suppliers who answer only with “meets CE/FCC” — those are foreign certifications and do not substitute for applicable Chinese GB where one exists.

Testing and laboratory accreditation

A test report is only as good as the lab behind it. Two marks matter:

  • CNAS (中国合格评定国家认可委员会, China National Accreditation Service): accreditation to ISO/IEC 17025 confirms the lab’s technical competence for specific tests. Check scope at www.cnas.org.cn.
  • CMA (检验检测机构资质认定, China Inspection Body & Laboratory Mandatory Approval): required for reports used for China-market supervision, filing or release; a CMA mark is what makes a report legally effective domestically.

For products destined for the Chinese market, prefer a CNAS + CMA lab whose accredited scope explicitly covers your product’s standard and test items. For export-only goods, a CNAS-accredited (or foreign ILAC-MRA) lab is usually sufficient, but confirm the importing country’s acceptance.

Beyond CCC: mandatory GB requirements

CCC (covered in a separate guide) applies to a defined catalogue. But many products outside the CCC catalogue still face mandatory GB safety, EMC, energy-efficiency or food-contact requirements. In 2026 SAMR tightened CCC supervision — moving 16 products (e.g., small-power motors, motor-vehicle safety glass) from self-declaration to third-party certification, strengthening post-certification surveillance, and advancing the “same line, same standard, same quality” (同线同标同质) action so domestic and export goods meet comparable requirements. The lesson: CCC is not the whole of conformity — map the full set of mandatory GB that touch your product.

Common pitfalls

  • Superseded versions: a report citing an old GB edition that has been replaced.
  • Wrong scope: a CNAS/CMA certificate that does not cover your exact product or test method.
  • “Factory self-test” passed off as independent: insist on an independent, accredited lab for conformity evidence.
  • Representative-sample gaps: the tested sample differs from mass-produced units (factory vs. production line).
  • Mismatch with destination rules: Chinese GB satisfied, but the destination market (EU/US/etc.) requires its own marks — plan for both.

A buyer’s due-diligence checklist

  1. Identify applicable standards via the national platform; note mandatory vs recommended and the in-force version.
  2. Require the supplier’s GB conformance matrix listing each applicable GB, version, and status.
  3. Demand independent test reports from CNAS (and CMA for China-market) labs whose scope matches.
  4. Verify lab credentials on CNAS/CNCA platforms before accepting reports.
  5. Check CCC scope — if the product is in the CCC catalogue, CCC is mandatory alongside GB.
  6. Contract the requirements: specify GB version, report validity, incoming inspection, and recall/rectification responsibility.
  7. Keep an audit file with dated originals; re-test on material or design change.
  8. Layer sector rules (food, cosmetics, medical devices, toys, electronics) on top of GB.

What to do next

  1. Build a standards register for your China-sourced product lines.
  2. Audit existing suppliers against the checklist; flag gaps.
  3. Specify GB conformance in new RFQs and contracts.
  4. Pre-shipment verification: independent re-test or document review for high-risk items.
  5. Monitor revisions of key GBs via the standards platform.

Sources

Related reading

  • Compulsory Product Certification (CCC) & Sourcing Compliance for Foreign Buyers
  • Supplier Due Diligence in China: a practical checklist
  • Export Control & Dual-Use Items: what foreign buyers must check

在华采购的产品标准、检测与国标(GB)合规:买家清单

概述

外资买家在华采购,价格与交期固然重要;但不符合中国(或目的地)标准的产品,可能意味着退运、召回、罚款与声誉受损。强制性产品认证(CCC)最引人注目,然而更广阔的国家标准(GB)、强制与推荐属性,以及第三方检测版图,才是许多采购合规漏洞真正的藏身之处。

本指南为外商投资企业及采购团队提供中国标准与检测体系、官方查询工具及尽调清单的务实地图——依据《标准化法》、市场监管总局/国家认监委规则及 CNAS 认可体系。

中国标准体系层级

中国技术标准呈层级结构:

  • 国家标准(”GB”): 分强制性(”GB”)与推荐性(”GB/T”)。强制性 GB 涉及健康、安全、环保与基础事项,具法律约束力。
  • 行业标准、地方标准、团体/企业标准位于国标之下,且不得低于强制性要求。

买家要点:产品在中国销售前(某些出口情形亦同)可能须符合强制性 GB。务必确认现行有效版本——标准会修订,使用已被替代的旧版是常见合规疏漏。

找到适用的标准

使用官方免费平台识别适用标准:

  • 全国标准信息公共服务平台——std.samr.gov.cn / www.samr.gov.cn:检索强制与推荐性国家标准,查看状态(现行/即将废止)及替代关系。
  • 国家标准全文公开系统——免费查阅绝大多数 GB 文本。

审核供应商时,要求其提供产品所依具体 GB 编号与版本,并与平台交叉核对。警惕仅以”符合 CE/FCC”作答的供应商——这些是外国认证,在有适用中国 GB 时不能替代。

检测与实验室认可

检测报告的价值取决于出具它的实验室。两个标志至关重要:

  • CNAS(中国合格评定国家认可委员会): 依据 ISO/IEC 17025 的认可,确认实验室对特定测试的技术能力,范围见 www.cnas.org.cn。
  • CMA(检验检测机构资质认定): 用于中国市场监督、备案或放行的报告必须具备;CMA 标志使报告在国内具法律效力。

面向中国市场的产品,宜优先选择CNAS + CMA且认可范围明确覆盖你产品标准与测试项的实验室。纯出口货物通常 CNAS 认可(或外国 ILAC-MRA)实验室即可,但须确认进口国接受。

超越 CCC:强制性 GB 要求

CCC(另文专述)适用于既定目录。但目录外众多产品仍须满足强制性 GB 安全、电磁兼容、能效或食品接触要求。2026 年市场监管总局强化 CCC 监管——将小功率电动机、机动车安全玻璃等 16 种产品由自我声明转为第三方认证,加强获证后监督,推进”同线同标同质”行动,使内外贸产品满足可比要求。启示:CCC 不等于全部符合性——须梳理触及你产品的全部强制性 GB。

常见陷阱

  • 版本被替代: 报告引用已被替代的旧版 GB。
  • 范围不符: CNAS/CMA 证书未覆盖你的确切产品或测试方法。
  • “工厂自检”冒充独立: 符合性证据应坚持由独立认可实验室出具。
  • 代表性样本缺口: 受检样品与量产不一致(工厂样 vs 产线样)。
  • 与目的地规则错配: 满足中国 GB,但目的地市场(欧盟/美国等)另有标志要求——须两者兼顾。

买家尽调清单

  1. 识别适用标准(经国家平台),注明强制/推荐与现行版本。
  2. 要求供应商提供 GB 符合性矩阵,列明每项适用 GB、版本与状态。
  3. 要求独立检测报告,来自范围匹配的 CNAS(中国市场另需 CMA)实验室。
  4. 在 CNAS/认监委平台核验实验室资质后再接受报告。
  5. 核查 CCC 范围——产品若属 CCC 目录,CCC 与 GB 须同时满足。
  6. 将要求写入合同:明确 GB 版本、报告有效期、进货检验与召回/整改责任。
  7. 留存带日期的原件审计档案;材料或设计变更时重测。
  8. 叠加行业规则(食品、化妆品、医疗器械、玩具、电子)于 GB 之上。

下一步建议

  1. 建立标准台账,覆盖在华采购的产品线。
  2. 按清单审计现有供应商,标注缺口。
  3. 在新 RFQ 与合同中明确 GB 符合性。
  4. 发货前验证: 高风险项做独立重测或文件复核。
  5. 通过标准平台监控关键 GB 的修订。

来源

相关阅读

  • 在华采购的强制产品认证(CCC)与合规清单
  • 在华供应商尽职调查:实操清单
  • 出口管制与两用物项:从中国采购的外资买家必须核查什么

Supply-Chain ESG and Labour Compliance in Supplier Due Diligence for Foreign-Invested Enterprises (2026)

  • China’s social-responsibility and ESG framework now expects foreign-invested enterprises (FIEs) to extend due diligence beyond their own walls to the suppliers they engage.
    中国的社会责任与ESG框架如今要求外商投资企业将尽职调查从自身延伸至其所合作的供应商。
  • The baseline is the national standard GB/T 36000-2015 (Guidance on Social Responsibility) and the CEFI-CSR reporting guide promoted by MOFCOM-affiliated bodies, which set out supplier social-responsibility admission and monitoring.
    基础依据是国家标准 GB/T 36000-2015《社会责任指南》以及商务部相关机构推行的外商投资企业社会责任报告编写指南,明确了供应商社会责任准入与监测。
  • Labour compliance is the highest-risk dimension: forced labour, child labour, and unsafe working conditions at a supplier can trigger criminal, administrative, and reputational liability for the buying FIE.
    劳工合规是风险最高的维度:供应商处的强迫劳动、童工与不安全作业,可能令采购方外资企业承担刑事、行政与声誉责任。
  • Environmental and data dimensions matter too — suppliers handling hazardous waste, conflict minerals, or personal information must meet permit, traceability, and PIPL obligations.
    环境与数据维度同样重要——涉及危废、冲突矿产或个人信息的供应商须满足许可、溯源与《个人信息保护法》义务。
  • Best practice is a dual-track mechanism: written ESG questionnaires plus on-site third-party audits (e.g., SMETA/RBA), backed by contractual ESG clauses, audit rights, and exit provisions.
    最佳实践是双轨机制:书面ESG问卷加第三方实地审核(如SMETA/RBA),并以合同ESG条款、审计权与退出条款为支撑。
  • FIEs should keep an auditable due-diligence evidence chain to satisfy regulators, customers, and cross-border ESG disclosure rules such as CBAM and EU directives.
    外商投资企业应保留可审计的尽调证据链,以应对监管机构、客户以及碳边境调节机制(CBAM)与欧盟指令等跨境ESG披露要求。

Supply-Chain ESG and Labour Compliance in Supplier Due Diligence for Foreign-Invested Enterprises (2026) | 外商投资企业供应链 ESG 与劳工合规供应商尽调(2026)

Why this matters now

For a foreign-invested enterprise (FIE) operating in China, supplier due diligence has moved well beyond price, quality, and delivery. Buyers are now expected — by Chinese regulators, by overseas customers, and by their own headquarters — to verify that suppliers respect labour rights, protect the environment, and handle data responsibly. A single supplier incident (forced labour allegations, a fatal safety accident, an illegal discharge, or a data leak) can halt shipments, trigger investigations, and damage a brand that took years to build.

This article explains the Chinese ESG and labour-compliance baseline for supplier due diligence, the highest-risk dimensions, a practical dual-track operating model, and the documentation an FIE should keep. It pairs with our supplier due-diligence and export-control coverage.

The Chinese baseline

China does not yet impose a single consolidated “supply-chain ESG due diligence” statute on domestic purchasers, but a coherent baseline already exists:

  • GB/T 36000-2015 (Guidance on Social Responsibility), the national standard aligned with ISO 26000, defines how organisations should address labour, environment, fair operating practices, and supply-chain responsibility.
  • The CEFI-CSR reporting guide (China Foreign-Funded Enterprises Social Responsibility Reporting Guide), promoted by MOFCOM-affiliated industry bodies, explicitly calls for a *supplier social-responsibility admission mechanism* — evaluating and selecting suppliers on labour practices, social impact, and environmental performance — and for ongoing monitoring.
  • The Labour Law, the Occupational Safety and Health regime, and the Production Safety Law impose direct obligations on employers; a buying FIE can be drawn into liability where it knowingly benefits from a supplier’s violations.
  • The Law on Prevention and Control of Environmental Pollution by Solid Waste and the PIPL (Personal Information Protection Law) reach into the supply chain wherever hazardous waste or personal data is involved.

MOFCOM’s 2025 *Guidance on FIEs Fulfilling Social Responsibility Overseas* reinforces the same logic for outbound supply chains and signals that ESG risk management is now part of responsible operation.

Highest-risk dimensions

Labour. Forced labour, child labour, and unsafe working conditions are the flashpoints. Article 244 of the Criminal Law criminalises forced labour; the Labour Law prohibits child labour and mandates occupational health and safety. An FIE that sources from a supplier with these defects faces not only reputational harm but also potential administrative penalties and, in egregious cases, criminal exposure under complicity or product-safety theories.

Environment. Suppliers generating hazardous waste, discharging wastewater, or handling conflict minerals (e.g., 3TG) must hold the correct permits and maintain traceability. A buyer’s name on a non-compliant supplier’s shipment can attract environmental-enforcement scrutiny and customer rejection under import-market ESG rules.

Data. Where a supplier processes personal information (e.g., HR records, customer data) on an FIE’s behalf, PIPL obligations — including a lawful basis, cross-border transfer mechanisms, and breach notification — extend to that processor. Due diligence should confirm the supplier’s data-handling controls.

A practical dual-track model

  1. Written ESG questionnaire. Capture basic facts: entity identity, licences, workforce profile, certifications (ISO 9001/14001/45001), environmental permits, and prior violations.
  2. Risk tiering. Classify suppliers by sector and exposure — high-risk tiers cover conflict minerals, high-energy-intensity processing, and labour-intensive assembly.
  3. On-site third-party audit. For high-risk suppliers, commission independent audits (SMETA, RBA, or equivalent) rather than relying on self-assessment.
  4. Contractual ESG clauses. Embed ESG commitments, audit rights, cure periods, and a compliance-termination right in procurement contracts.
  5. Dynamic rating and exit. Maintain an internal ESG score; trigger remediation or offboarding for persistent underperformance, preserving the evidence chain.

Documentation to keep

FIEs should retain, for at least the relevant limitation period, the questionnaire responses, audit reports, corrective-action plans, contractual clauses, and training records. This evidence chain is what regulators, customers, and cross-border disclosure regimes (the EU CBAM, the EU battery and deforestation regulations, and similar directives) will ask to see. Treating supplier ESG due diligence as a documented programme — not a one-off checklist — is the cheapest insurance against disruption.

Related reading

  • Supplier due diligence and export-control screening for foreign-invested enterprises.
  • PIPL and cross-border data transfer compliance for HR and operations.
  • Environmental permitting and hazardous-waste compliance for manufacturers in China.

外商投资企业供应链 ESG 与劳工合规供应商尽调(2026)/ Supply-Chain ESG and Labour Compliance in Supplier Due Diligence for Foreign-Invested Enterprises (2026)

为何重要

对在中国运营的外商投资企业而言,供应商尽职调查早已超越价格、质量与交期。如今,采购方须同时面对中国监管机构、海外客户与集团总部的期待,核实供应商是否尊重劳工权益、保护环境并妥善处置数据。一次供应商事件——强迫劳动指控、致命安全事故、违法排放或数据泄露——就可能中断发货、引发调查,并摧毁多年积累的品牌的信任。

本文说明中国语境下供应商尽调的 ESG 与劳工合规基线、最高风险维度、可落地的双轨操作模型,以及外资企业应当留存的文档,与本站供应商尽调与出口管制专题相互呼应。

中国基线

中国尚未对境内采购方出台单一的”供应链 ESG 尽调”成文法,但一套连贯的基线已经存在:

  • GB/T 36000-2015《社会责任指南》——与 ISO 26000 接轨的国家标准,界定组织应如何对待劳工、环境、公平运营及供应链责任。
  • 中国外商投资企业社会责任报告编写指南(CEFI-CSR)——由商务部相关机构推行的指引,明确要求建立*供应商社会责任准入机制*,从劳工实践、社会影响与环境影响等维度评价并选择供应商,并持续监测。
  • 《劳动法》《职业病防治法》《安全生产法》对用人单位施加直接义务;采购方若在知情情形下受益于供应商的违规,亦可能被卷入责任。
  • 《固体废物污染环境防治法》与《个人信息保护法》(PIPL)在涉及危废或个人信息的环节延伸至供应链。

商务部 2025 年《企业境外履行社会责任工作指引》对走出去的供应链重申了同样的逻辑,释放出 ESG 风险管理已成为负责任经营组成部分的信号。

最高风险维度

劳工。强迫劳动、童工与不安全作业是引爆点。《刑法》第二百四十四条将强迫劳动入罪;《劳动法》禁止童工并规定职业健康安全。从存在这些缺陷的供应商处采购的外资企业,不仅面临声誉损害,还可能招致行政处罚,情节严重时依共犯或产品安全理论承担刑事责任。

环境。涉及危废、废水排放或冲突矿产(如 3TG)的供应商须持有效许可并保持溯源。采购方名字出现在不合规供应商的货单上,可能引发环保执法关注,并在进口市场 ESG 规则下遭客户拒收。

数据。当供应商代表外资企业处理个人信息(如人事档案、客户数据)时,PIPL 义务——包括合法基础、跨境传输机制与泄露通知——延伸至该处理者。尽调应确认供应商的数据处置控制能力。

可落地的双轨模型

  1. 书面 ESG 问卷。采集基本事实:主体身份、执照、用工结构、体系认证(ISO 9001/14001/45001)、环保许可与既往违规。
  2. 风险分层。按行业与敞口对供应商分类——高危层涵盖冲突矿产、高能耗加工与劳动密集型组装。
  3. 第三方实地审核。对高危供应商委请独立审核(SMETA、RBA 或等效),而非仅依赖自评。
  4. 合同 ESG 条款。在采购合同中嵌入 ESG 承诺、审计权、整改期限与合规解约权。
  5. 动态评级与退出。建立内部 ESG 评分;对持续不达标者触发整改或退出,并保留证据链。

应留存的文档

外资企业应将问卷回复、审核报告、整改计划、合同条款与培训记录至少保留至相关时效期满。这条证据链,正是监管机构、客户以及跨境披露制度(欧盟碳边境调节机制 CBAM、电池与反 deforestation 法规及类似指令)会要求出示的材料。将供应商 ESG 尽调视为一项有文档支撑的常态化机制,而非一次性勾选清单,是防范中断最经济的风险对冲。

延伸阅读

  • 外商投资企业的供应商尽调与出口管制筛查。
  • 人力资源与运营中的 PIPL 及跨境数据传输合规。
  • 中国制造企业的环保许可与危废合规。

Sources

  • 商务部 中国外商投资企业协会:《中国外商投资企业社会责任报告编写指南(CEFI-CSR1.0)》— https://images.mofcom.gov.cn/caefi/201801/20180109102351464.pdf
  • 国家市场监督管理总局 国家标准委:GB/T 36000-2015《社会责任指南》— https://std.samr.gov.cn/
  • 人力资源和社会保障部:《中华人民共和国劳动法》— http://www.mohrss.gov.cn/
  • 商务部:《企业境外履行社会责任工作指引》(2025-12-05)— https://be.mofcom.gov.cn/jmxw/art/2026/art_55c2cab9499443c9bcee6a9f7df47da8.html

Foreign-Invested Insurance and Reinsurance Market Access in China

  • China has abolished foreign equity-ratio caps in life insurance, insurance asset management and related sub-sectors, and applies pre-establishment national treatment plus a negative list to foreign-invested insurers.
    中国已取消人身险、保险资管等子行业的外资持股比例限制,并对在华外资保险机构全面实施准入前国民待遇加负面清单管理。
  • The 2026 “Several Measures to Accelerate the Building of the Shanghai International Reinsurance Centre” (NFRA + Shanghai, 16 June 2026) opens the Lin-gang area to foreign reinsurance acceptors and brokers through a registration and trading centre.
    2026年6月16日国家金融监督管理总局与上海市人民政府联合印发《加快上海国际再保险中心建设的若干措施》,依托登记交易中心向境外再保险接受人、再保险经纪人开放临港新片区市场。
  • Foreign-invested insurance asset management has moved from approval to reality: Allianz’s wholly foreign-owned insurance asset manager (2021), Prudential’s (2025) and AIA and NN IP managers opening in Shanghai by end-2025.
    外资保险资管已从审批走向落地:安联(中国)保险资管(2021年)、保德信保险资管(2025年)先后获批,友邦保险资管与荷全保险资管于2025年底在沪开业。
  • The State Council’s action plan to attract foreign investment explicitly supports qualified foreign professional insurers in setting up or taking stakes in domestic insurance institutions, deepening pension and health insurance opening.
    国务院办公厅《扎实推进高水平对外开放更大力度吸引和利用外资行动方案》明确支持符合条件的境外专业保险机构在中国境内投资设立或参股保险机构,深化养老保险、健康保险等行业开放。
  • Foreign insurers should plan market entry around three routes — greenfield wholly foreign-owned company, stake-building or M&A, or an insurance asset-management subsidiary — each with distinct licensing and capital paths.
    外资保险机构应围绕三条路径规划准入:新设外商独资公司、参股控股现有机构,或设立保险资管子公司,三者在牌照与资本要求上各有不同。
  • The 2026 Government Work Report’s “steady expansion of institutional opening” signals a shift from threshold relaxation to rules, regulation, management and standards alignment that favours long-term foreign commitment.
    2026年《政府工作报告》提出”稳步扩大制度型开放”,标志着开放重心从放宽准入门槛转向规则、规制、管理、标准对接,更有利于外资长期深耕。

Foreign-Invested Insurance and Reinsurance Market Access in China | 外资保险与再保险机构在华市场准入

Why this matters now

For a foreign financial group weighing China, the insurance sector is no longer a question of *whether* foreign ownership is permitted, but *how* to enter and operate under an increasingly mature, institution-based opening framework. Two forces converge in 2026. First, the removal of foreign equity caps in life insurance and insurance asset management means ownership structure is now a commercial choice, not a regulatory ceiling. Second, Beijing is explicitly pivoting from “element-type opening” (relaxing entry thresholds) to “institutional opening” — aligning rules, regulation, management and standards with international practice. The practical result is a market where foreign insurers can own, control and manage, but must navigate a licensing and supervision architecture that rewards long-term, locally-rooted commitment.

The opening trajectory: from element to institution

China’s insurance opening has proceeded in deliberate stages. Earlier rounds lifted the foreign equity ceiling in life insurance to 51% and then removed it; insurance asset management and other sub-sectors followed. Today the baseline regime is pre-establishment national treatment plus a negative list, with regulators emphasising transparent, standardised administrative licensing. The 2026 Government Work Report frames the next phase as “steady expansion of institutional opening” and “strengthening service guarantees for foreign-funded enterprises” — language that points to procedural fairness and post-entry treatment rather than further threshold cuts.

Market data underline the shift. Global insurers among the world’s largest have steadily entered; several have converted joint ventures into wholly foreign-owned life insurers, and a cluster of foreign insurance asset managers has been licensed in Shanghai. The message for investors is that the policy tailwind now concentrates on *operating depth* — local asset management, in-country reinsurance, and participation in China’s risk-pooling — rather than on mere market access.

The 2026 Shanghai international reinsurance centre measures

The most concrete 2026 signal is the Several Measures to Accelerate the Building of the Shanghai International Reinsurance Centre (National Financial Regulatory Administration, NFRA, together with the Shanghai Municipal People’s Government, dated 16 June 2026). The measures aim to turn the China (Shanghai) Pilot Free Trade Zone’s Lin-gang area into a globally connected reinsurance hub. Key provisions:

  • Encourage large enterprises to concentrate risk-protection demand in Lin-gang and match it with underwriting capacity.
  • Support domestic reinsurers in building the registration and trading centre, and allow foreign reinsurance acceptors and reinsurance brokers to conduct referral and trading business through that centre, bringing overseas capacity into the China market.
  • Promote unified registration of reinsurance contracts and claims, upgrade data governance and security, and build a transparent digital trading platform.
  • Facilitate cross-border business: allow reinsurers to open custodial and settlement accounts in Lin-gang, apply the convenient offshore-investment policy for cross-border reinsurance ceded-income, and update the reinsurance data-export operational guideline.

For a foreign reinsurer or broker, these measures lower the friction of participating in China’s reinsurance market and create a defined onshore platform — a meaningful alternative to serving China risk purely from offshore.

Three market-entry routes for foreign insurers

Route one — greenfield wholly foreign-owned insurer. Suitable where the investor wants full control of a life, property or health carrier. Requires meeting solvency, fit-and-proper, and corporate-governance standards; the removal of equity caps means 100% ownership is permissible. Approval and licensing follow the standard insurance company formation path under NFRA.

Route two — stake-building or M&A in an existing insurer. Common for entering via a joint venture that is later consolidated to majority or full foreign ownership. This route reuses an existing licence and distribution footprint but demands careful handling of minority protections, connected-transaction rules and change-of-control approvals.

Route three — insurance asset-management subsidiary. Increasingly the preferred depth play. A foreign insurer (or its headquarters) can establish a wholly foreign-owned insurance asset manager to separate balance-sheet asset allocation from investment execution. The recent Shanghai licensings of foreign insurance asset managers show this route is operational and actively welcomed in the pilot free-trade zone.

Practical steps and licensing checklist

  1. Choose the ownership-and-entity route first. The licensing path, capital adequacy and governance expectations differ sharply between a carrier, a stake acquisition and an asset manager.
  2. Engage NFRA early. Pre-application consultation clarifies solvency, qualification of directors/senior managers, and business-plan expectations before formal filing.
  3. Localise capital and talent. Demonstrated in-China risk-management capability and a credible local management team are routinely expected, not optional.
  4. Plan for the reinsurance and asset-management angle. Even a primary carrier should map how it will cede risk (potentially through the Shanghai centre) and manage assets (potentially through a local insurance asset manager).
  5. Track pilot free-trade-zone preferences. Shanghai (reinsurance), Hainan (cross-border insurance services) and the nine-city service-opening pilot offer concrete, often faster, onshore footholds.

Related reading

The same institutional-opening logic now extends across banking, securities and fund management. Foreign groups should read China’s insurance access alongside the broader financial-opening roadmap and the foreign-investment action plan, because the licensing, capital and supervision expectations are increasingly coordinated across the financial sector.


外资保险与再保险机构在华市场准入

为何当下值得关注

对考虑进入中国的外资金融集团而言,保险行业的关键已不再是”是否允许外资持股”,而是”在日益成熟、以制度型开放为底色的框架下如何准入与运营”。2026年两股力量交汇:其一,人身险、保险资管等子行业的外资持股比例限制已被取消,股权结构成为商业选择而非监管上限;其二,决策层正明确从”要素型开放”(放宽准入门槛)转向”制度型开放”——推动规则、规制、管理、标准与国际接轨。其结果是一个外资可以控股、控制并经营,但必须经由一套以透明许可与属地监管为核心的架构的市场,且这套架构更利好长期、在地深耕的承诺。

开放脉络:从要素型走向制度型

中国保险业的开放循序渐进。早期将外资寿险股比上限提至51%,随后彻底取消;保险资管等子行业陆续跟进。当前的基准制度已是”准入前国民待遇加负面清单”,监管部门强调行政许可的透明与标准化。2026年《政府工作报告》将下一阶段概括为”稳步扩大制度型开放”与”加强对外资企业的服务保障”——这一表述指向程序公平与准入后待遇,而非进一步的门槛削减。

市场数据印证了这种转向。全球大型保险集团持续进入;多家已将合资寿险公司转为外商独资人寿,且一批外资保险资管公司在上海获批。对投资者而言,政策顺风正集中于”运营深度”——在地资产管理、在岸再保险、参与中国风险分担——而非单纯的准入放宽。

2026年上海国际再保险中心措施

2026年最具实操意义的信号,是国家金融监督管理总局与上海市人民政府于2026年6月16日联合印发的《加快上海国际再保险中心建设的若干措施》。该措施旨在将中国(上海)自由贸易试验区临港新片区打造为连通全球的再保险枢纽。要点包括:

  • 鼓励大型企业在临港新片区集中管理风险保障需求,推动风险与承保能力精准对接。
  • 支持境内再保险机构建设登记交易中心,并允许境外再保险接受人、再保险经纪人通过该中心开展引荐与交易业务,将境外承保能力引入中国市场。
  • 推动再保险合同、赔付等信息统一登记,完善数据分级分类治理与安全保密,建设高效透明的数字化交易平台。
  • 便利跨境业务:支持再保险机构在临港开立托管与结算专用账户,运用跨境再保险分入业务收入境外投资便利化政策,并更新再保险数据出境操作指引。

对外资再保险人与经纪人而言,这些措施降低了参与中国再保险市场的摩擦,并提供清晰的在岸平台——成为单纯离岸服务中国风险之外的重要替代路径。

外资保险机构的三条准入路径

路径一——新设外商独资保险公司。 适用于希望完全掌控寿险、财险或健康险主体的投资者。需满足偿付能力、高管适格与公司治理标准;股比限制取消后,100%持股已被允许。审批与牌照遵循国家金融监管总局标准的人身险/财险公司设立路径。

路径二——参股或并购现有保险机构。 常见做法是先以合资进入,再逐步增持至控股或独资。该路径可复用既有牌照与渠道,但须审慎处理少数股东保护、关联交易规则及控制权变更审批。

路径三——设立保险资管子公司。 日益成为”深度布局”的首选。外资保险机构(或其总部)可设立外商独资保险资管公司,将寿险板块的资产配置规划与资管公司的实际投资运作分开。近期多家外资保险资管公司在上海获批开业,表明该路径已可落地且受到试点自贸区欢迎。

实务步骤与牌照清单

  1. 先定股权与实体路径。 保险公司、股权收购、保险资管三者的许可路径、资本充足与治理预期差异显著。
  2. 尽早对接监管机构。 正式申报前先行沟通,厘清偿付能力、董事及高管适格、业务规划等预期。
  3. 资本与人才在地化。 具备在China的风险管理能力与可信的本地管理团队,是常态要求而非可选项。
  4. 规划再保险与资管维度。 即便作为直接承保人,也应谋划分保路径(可经由上海中心)与资产管理路径(可设立本地保险资管)。
  5. 追踪试点自贸区优惠。 上海(再保险)、海南(跨境保险服务)及九城市服务业扩大开放综合试点,提供具体、往往更快的在岸落脚点。

延伸阅读

同一套制度型开放逻辑已延伸至银行、证券与基金管理。外资集团应将保险准入与中国整体金融开放路线图及稳外资行动方案一并研读,因为金融各子行业的许可、资本与监管预期正日益协同。

Sources

  • 国家金融监督管理总局、上海市人民政府:《加快上海国际再保险中心建设的若干措施》(2026-06-16)— https://www.nfra.gov.cn/cn/view/pages/ItemDetail.html?docId=1263701&generaltype=1&itemId=861
  • 国务院办公厅:《扎实推进高水平对外开放更大力度吸引和利用外资行动方案》(扩大银行保险领域外资金融机构准入)— https://www.sc.gov.cn/10462/13241/2024/3/20/d53b63a89ffa44dbab74dd4ec57b611e.shtml
  • 2026年《政府工作报告》”稳步扩大制度型开放”(金融时报,武汉市地方金融工作局转载)— https://jrj.wuhan.gov.cn/ztzl_57/xyrd/bxy/202603/t20260325_2744635.shtml

Non-Resident Taxpayers Claiming Tax-Treaty Benefits: A 2026 Compliance Guide for Foreign-Invested Enterprises

  • Non-resident taxpayers claim China tax-treaty benefits on a “self-assess, file-to-enjoy, retain-documents” basis — there is no advance approval or record-filing step.
    非居民纳税人享受中国税收协定待遇采取”自行判断、申报享受、相关资料留存备查”方式,无需事前审批或备案。
  • The governing rule is SAT Announcement 2019 No. 35, effective 1 January 2020, replacing the old prior-approval regime for treaty benefits.
    主管规则为国家税务总局公告2019年第35号,自2020年1月1日起施行,取代原有的协定待遇审批制。
  • There are two claim paths: the non-resident files the Information Report Form with its own CIT return, or submits it to the Chinese withholding agent who attaches it to the withholding return.
    两条享受路径:非居民纳税人在自行申报时报送《非居民纳税人享受协定待遇信息报告表》,或在源泉扣缴下将报告表提交给中国扣缴义务人、由其作为扣缴申报附表报送。
  • Four categories of documents must be retained for inspection: tax-residency certificate, transaction evidence, “beneficial owner” proof for dividends/interest/royalties, and any other supporting material.
    须留存备查四类资料:税收居民身份证明、交易权属证明、股息/利息/特许权使用费的”受益所有人”证明及其他佐证。
  • For an FIE, the treaty-benefit rule bites when it pays outbound dividends, interest, royalties, or service fees to a foreign related party — the FIE is the withholding agent, not the beneficiary.
    对外商投资企业而言,协定待遇规则在其向境外关联方支付股息、利息、特许权使用费或服务费时触发——此时外商投资企业是扣缴义务人而非受益方。
  • The “beneficial owner” test (SAT Announcement 2018 No. 9) guards against treaty shopping; conduit or mailbox companies may be denied the reduced rate.
    “受益所有人”测试(国家税务总局公告2018年第9号)防范协定滥用,导管公司或信箱公司可能被拒享低税率。
  • Wrongly claimed benefits trigger back-tax and late-payment penalties; over-paid tax can be refunded within the statute of limitations on voluntary correction.
    错误享受将补缴税款并加收滞纳金;多缴税款可在征管法规定的期限内主动申请退还。

Non-Resident Taxpayers Claiming Tax-Treaty Benefits: A 2026 Compliance Guide for Foreign-Invested Enterprises | 非居民纳税人享受税收协定待遇:外商投资企业2026合规指引

Why this matters now

A foreign-invested enterprise in China rarely operates without cross-border flows: dividends upstreamed to an offshore parent, interest on intra-group loans, royalties for trademarks or technology, or fees for offshore management and technical services. Each outbound payment is a Chinese taxable event for the foreign recipient, and each carries a statutory withholding rate — typically 10% on dividends, interest, and royalties under the Enterprise Income Tax Law. But China has signed comprehensive double-taxation agreements (DTAs) with more than 110 jurisdictions, and most of those treaties, plus the Mainland–Hong Kong and Mainland–Macau arrangements, cut the rate substantially — often to 5% for qualifying dividends and 6% or 7% for royalties.

The catch is that the lower treaty rate is not automatic. It must be claimed, and the mechanism for claiming it is the *Administrative Measures for Non-resident Taxpayers Claiming Tax Treaty Benefits* (SAT Announcement 2019 No. 35). Many FIE finance teams still treat treaty relief as something a tax bureau must pre-approve; since 2020 it is the taxpayer’s self-service election, with the compliance burden squarely on the non-resident and its Chinese withholding agent. Understanding the path, the forms, and the retained evidence is now core FIE tax hygiene.

The legal basis: Announcement 2019 No. 35

SAT Announcement 2019 No. 35, promulgated on 14 October 2019 and effective from 1 January 2020, replaces the prior-approval system (the old “record and review” or pre-approval route under Announcement 2015 No. 60) with a self-service model. Its Article 3 states the governing principle in plain terms: non-resident taxpayers enjoy treaty benefits by means of “self-discretion, filing for eligibility, and retention of relevant materials for future review.”

The Measures apply to any non-resident taxpayer that has a Chinese tax obligation and intends to enjoy a treaty benefit. “Treaty” is defined broadly — it covers bilateral tax conventions and also international transport agreements (air, maritime, road, and vehicle transport, plus mutual-exemption exchanges). The benefit itself is a reduction or exemption of enterprise or individual income tax that would otherwise be due under domestic law. Crucially, the Mainland–Hong Kong and Mainland–Macau arrangements are explicitly brought within the same procedure.

How to claim: the self-assessment model

There is no pre-approval. The non-resident taxpayer assesses its own eligibility against the relevant treaty article and, if it concludes it qualifies, simply enjoys the reduced rate at the point of filing or withholding. Three consequences follow:

  1. The non-resident bears full legal responsibility for the truth, accuracy, and lawfulness of the information it reports and the documents it keeps.
  2. The withholding agent that relies on the non-resident’s form is not separately liable for the underlying eligibility — but it must still withhold correctly and file the form as an annex.
  3. Relief is subject to ex-post follow-up administration: the tax authority can, at any time, demand the retained documents and reconstruct the correct tax.

This “trust-but-verify-later” design lowers the friction of claiming relief but raises the cost of getting it wrong.

Two filing paths

The Measures provide two distinct routes depending on how the non-resident is taxed in China:

Path A — non-resident self-filing. Where the non-resident files its own enterprise income tax return (for example, a non-resident with a Chinese establishment reporting on an actual basis, or a non-resident making a direct CIT filing), it submits the *Information Report Form for Non-resident Taxpayers Claiming Treaty Benefits* together with the return and retains the supporting documents per Article 7.

Path B — withholding (most common for FIEs). Where tax is withheld at source or by a designated withholding agent, the non-resident fills in the Information Report Form, proactively hands it to the Chinese withholding agent, and retains its documents. The withholding agent confirms the form is complete, withholds at the treaty rate, and files the form as a supplementary schedule to the withholding return. If the non-resident fails to submit the form or fills it incompletely, the withholding agent withholds at the domestic statutory rate — the benefit is simply lost for that payment.

For the typical FIE, Path B is the live one: the FIE is the withholding agent on every outbound dividend, interest, royalty, or service fee, and the foreign parent or affiliate is the non-resident taxpayer that must supply the form.

Documents to retain

Article 7 lists four buckets of retained-for-inspection material. The non-resident (not the FIE) is the keeper, but the FIE should insist on seeing them before it relies on the lower rate:

  • Tax-residency certificate. Issued by the treaty partner’s tax authority for the current or prior year, proving the recipient is a tax resident of that jurisdiction. For international-transport treaty claims, an equivalent identity proof may substitute.
  • Transaction evidence. Contracts, agreements, board or shareholder resolutions, and payment vouchers establishing the nature, amount, and entitlement to the income.
  • Beneficial-owner proof. Required only for dividend, interest, and royalty claims — the recipient must show it is the “beneficial owner” of the income, not a mere conduit.
  • Any other material the non-resident believes supports its eligibility.

Foreign-language originals must be accompanied by a Chinese translation for which the taxpayer bears responsibility. Documents are kept for the period prescribed by the Tax Collection and Administration Law and its implementing rules.

Beneficial owner and anti-treaty-shopping

The single most litigated gate is the “beneficial owner” test, governed by SAT Announcement 2018 No. 9. A recipient that is a passive holding or “mailbox” company, or that is contractually or practically obliged to pass the income straight up to a different group entity, will be treated as a conduit and denied treaty relief even if it holds a residency certificate. Announcement 2018 No. 9 offers safe harbours — for example, where the recipient is the ultimate parent or meets certain ownership and business-substance conditions — but the analysis is fact-intensive. FIEs should not assume that routing a royalty through a low-tax holding company automatically earns the treaty rate; the substance of that entity is what the authority will probe in follow-up.

Practical steps for FIEs making outbound payments

  1. Identify the treaty. Determine which DTA or arrangement applies to the foreign recipient and the specific article (dividends, interest, royalties, services/technical fees, or business profits).
  2. Request the form early. Ask the non-resident to complete the Information Report Form and supply the tax-residency certificate and beneficial-owner evidence *before* the payment date, not after.
  3. Verify completeness. Confirm the form is filled and the residency certificate covers the relevant year; otherwise withhold at 10%.
  4. Withhold and file. Apply the treaty rate, remit the tax, and attach the form to the withholding return through the electronic tax bureau.
  5. Keep your own file. Although the non-resident retains the evidence, the FIE should keep a copy of the form and a record of its verification for its own audit defence.
  6. Correct mistakes promptly. If a benefit was wrongly enjoyed, proactively make up the tax and late payment; if over-withheld, the non-resident may claim a refund within the limitation period.

Common pitfalls and follow-up risk

The most frequent errors are: relying on an expired or wrong-jurisdiction residency certificate; claiming a royalty rate the treaty does not grant (many treaties tax royalties at 6%–10%, not 0%); ignoring the beneficial-owner analysis for a conduit holding company; and failing to attach the form to the withholding return, so the relief is never recorded. Because the regime is ex-post, a routine follow-up can reopen payments several years back. Treating the treaty claim as a documented, per-payment control — not an annual afterthought — is the cheapest way for an FIE to avoid a costly adjustment.

Related reading

  • See our articles on related-party disclosure and contemporaneous documentation, and on corporate tax residency and CFC rules, for the wider FIE cross-border tax picture.

非居民纳税人享受税收协定待遇:外商投资企业2026合规指引

为何当下重要

在中国的外商投资企业几乎无法脱离跨境资金流动而运营:向上游境外母公司分配的股息、集团内贷款的利息、商标或技术的特许权使用费,或离岸管理与技术服务的费用。每一笔对外支付对外国收款方而言都是中国的应税事件,且均适用法定扣缴税率——依《企业所得税法》,股息、利息、特许权使用费通常为10%。但中国已与110多个税收管辖区签署了全面的避免双重征税协定(DTA),其中大多数协定以及内地与香港、澳门的安排,都将税率大幅降低——符合条件的股息常降至5%,特许权使用费降至6%或7%。

关键在于,较低的协定税率并非自动适用,必须主动申请。申请的机制即《非居民纳税人享受税收协定待遇管理办法》(国家税务总局公告2019年第35号)。许多外商投资企业财务团队仍把协定优惠视为需税务机关事前审批的事项;而自2020年起,这已成为纳税人自助选择的事项,合规责任完全落在非居民及其中国扣缴义务人身上。理解申报路径、表单与留存证据,已成为外商投资企业的基础税务素养。

法律基础:2019年第35号公告

国家税务总局公告2019年第35号于2019年10月14日发布,自2020年1月1日起施行,以自助模式取代了原有的事前审批制(即2015年第60号公告下的”备案+审核”或审批路径)。其第三条规定了简明的原则:非居民纳税人享受协定待遇,采取”自行判断、申报享受、相关资料留存备查”方式办理。

该办法适用于任何在中国境内发生纳税义务并有意愿享受协定待遇的非居民纳税人。”协定”定义宽泛——涵盖双边税收协定及国际运输协定(航空、海运、道路、汽车运输及互免国际运输收入税收协议或换函)。待遇本身指依国内税法本应缴纳的企业所得税或个人所得税得以减轻或免除。值得强调的是,内地与香港、澳门特别行政区的安排明确纳入同一程序。

如何享受:自行判别模式

无需事前审批。非居民纳税人自行对照相关协定条款判断资格,若认定符合条件,即在申报或扣缴环节直接享受低税率。由此产生三项后果:

  1. 非居民对其填报信息的真实性、准确性、合法性及留存资料的合规承担全部法律责任。
  2. 依非居民填报信息扣缴的扣缴义务人,不就资格本身另担责任——但仍须正确扣缴并将表单作为附表报送。
  3. 待遇接受事后后续管理:税务机关可随时调阅留存资料并重新计算正确税额。

这种”先信任、后核验”的设计降低了享受优惠的摩擦,却提高了出错成本。

两条申报路径

办法依非居民在中国的征税方式,规定了两条不同路径:

路径甲——非居民自行申报。 非居民自行申报企业所得税时(如在中国境内设立机构、场所并据实申报的非居民,或自行办理企业所得税申报的非居民),在报送申报表的同时提交《非居民纳税人享受协定待遇信息报告表》,并按第七条留存资料。

路径乙——扣缴(外商投资企业最常见)。 在源泉扣缴或指定扣缴情形下,非居民如实填写报告表,主动提交给中国扣缴义务人,并依第七条留存资料。扣缴义务人确认信息完整后,按协定税率扣缴,并将报告表作为扣缴申报附表报送主管税务机关。若非居民未主动提交或填报不完整,扣缴义务人依国内税法规定扣缴——该笔支付即丧失优惠。

对典型外商投资企业而言,路径乙是常态:外商投资企业是每笔对外股息、利息、特许权使用费或服务费的扣缴义务人,而外国母公司或关联方才是须提供表单的非居民纳税人。

应留存备查的资料

第七条列明四类留存备查资料。虽然保管责任在非居民(而非外商投资企业),但外商投资企业应在依低税率扣缴前坚持审阅:

  • 税收居民身份证明。 由协定缔约对方税务主管当局就取得所得的当年度或上一年度开具,证明收款方为该管辖区税收居民。享受国际运输条款待遇的,可以相应身份证明代替。
  • 交易权属证明。 与所得相关的合同、协议、董事会或股东会决议、支付凭证等,用以确立收入的性质、金额与归属。
  • “受益所有人”证明。 仅股息、利息、特许权使用费条款须提供——收款方须证明其是该收入的”受益所有人”,而非单纯导管。
  • 其他佐证。 非居民认为能证明其符合享受条件的其他资料。

外文原件按要求提供时须附中文译本,纳税人对译本准确性与完整性负责。资料依《税收征收管理法》及其实施细则规定的期限保存。

受益所有人与反协定滥用

最具争议的关口是”受益所有人”测试,由国家税务总局公告2018年第9号规范。若收款方为被动持股的”信箱”公司,或在合同或事实上须将收入即刻上缴另一集团实体,则会被认定为导管,即使持有居民证明也会被拒享协定待遇。2018年第9号提供了安全港——例如收款方为最终母公司或满足特定持股与经营实质条件——但分析高度依赖事实。外商投资企业不应想当然地认为通过低税控股公司通道支付特许权使用费即可自动适用协定税率;税务机关在后续管理中审视的正是该实体的实质。

外商投资企业对外支付的实操步骤

  1. 确定适用协定。 明确外国收款方适用哪一条DTA或安排及具体条款(股息、利息、特许权使用费、服务/技术费或营业利润)。
  2. 尽早索取表单。 要求非居民在付款日前(而非之后)填妥报告表,并提供税收居民身份证明与受益所有人证据。
  3. 核验完整性。 确认表单填妥且居民证明覆盖相关年度;否则按10%扣缴。
  4. 扣缴并申报。 适用协定税率,解缴税款,并通过电子税务局将表单作为扣缴申报附表报送。
  5. 留存自身档案。 尽管证据由非居民保管,外商投资企业仍应留存表单副本及核验记录,以作自身稽查抗辩。
  6. 及时更正错误。 若错误享受,主动补缴税款与滞纳金;若多扣缴,非居民可在法定期限内申请退还。

常见误区与后续风险

最频繁的失误包括:依赖过期或错误管辖区的居民证明;主张协定并未给予的特许权使用费税率(许多协定对特许权使用费适用6%–10%而非0%);忽视导管控股公司的受益所有人分析;以及未将表单附于扣缴申报,导致优惠从未被记录。由于该制度是事后管理,一次例行后续核查可追溯数年前的支付。将协定申请视为一项逐笔留存文档的控制动作——而非年度补做事项——是外商投资企业避免高额调整最经济的方式。

延伸阅读

  • 请参阅我们关于关联申报与同期资料、以及企业税收居民与受控外国企业规则的专题,了解更完整的外资企业跨境税务图景。

Sources

Power battery supply chain — foreign opportunities and localisation

  • China’s power-battery manufacturing is fully open to foreign investment, but the 2024 MIIT “Comprehensive Utilisation of End-of-Life NEV Power Batteries (2024 Edition)” norm tightens recycling, traceability and technical thresholds.
    中国动力电池制造对外资完全开放,但工信部2024年《新能源汽车废旧动力电池综合利用行业规范条件(2024年本)》提高了回收、溯源与技术门槛。
  • Every power battery must carry a unique identification code tracked through the national traceability platform from production to retirement; producers bear extended-producer-responsibility obligations.
    每块动力电池须具唯一识别编码,经国家溯源平台从生产追踪至退役;生产者承担生产者责任延伸义务。
  • Export markets impose their own local-content and carbon rules: the US 301 tariffs raise Chinese EV/battery duties (EVs to 100% from 2024), and the EU Battery Regulation mandates carbon-footprint declarations and a battery passport.
    出口市场设有本地含量与碳规则:美国301关税上调中国电动车/电池税率(2024年起电动车达100%),欧盟新电池法要求碳足迹声明与电池护照。
  • Recycling scale is being built: by early 2026 China had 148 announced compliant enterprises and provincial clusters (Ganzhou, Changsha); the 2025 State Council action plan targets a standardised, efficient recovery system.
    回收规模正在形成:截至2026年初中国已公告148家合规企业并形成赣州、长沙等集群;2025年国务院行动方案目标是规范化、高效回收体系。
  • Foreign battery firms can manufacture in China but must meet the same GB/catalogue and recycling obligations as domestic players; a non-compliant pack can block the whole vehicle’s type approval.
    外资电池企业可在中国制造,但须满足与本土企业同等的GB/目录与回收义务;不合规电池包可拖垮整车准入。
  • Localisation of cells, materials and recycling is now driven less by a mandated JV ratio and more by cost, lead-time, and customer (OEM) ESG/sourcing requirements.
    电芯、材料与回收的本地化,如今更少由强制合资比例驱动,更多由成本、交期与整车厂ESG/采购要求驱动。
  • Opportunities sit in high-value segments: LFP/high-nickel cells, separator/electrolyte materials, recycling and refurbishment, and battery-swap/energy-storage co-location.
    机会在于高价值环节:磷酸铁锂/高镍电芯、隔膜电解液材料、回收再利用,以及换电/储能协同。

Power battery supply chain — foreign opportunities and localisation | 动力电池产业链:外资机会与本地化配套

Overview

China hosts the world’s densest and lowest-cost power-battery supply chain — from cathode and anode materials to cells, packs, BMS and recycling. For foreign battery makers and the OEMs that buy from them, the sector is legally open: there is no foreign-ownership cap on battery manufacturing, and the 2024 negative list cleared manufacturing-sector restrictions generally.

The practical question in 2026 is not “may I invest” but “how do I meet China’s tightening recycling, traceability and technical rules while competing on a supply chain that is rapidly localising and, at the same time, navigating US and EU trade and carbon barriers abroad.” This article outlines the regulatory floor, the localisation logic, and where foreign capital can still win.

The regulatory floor: type approval, catalogue and traceability

Beyond general manufacturing access, batteries sit under a specific regime. The MIIT “Roadmap”/catalogue system and battery-recycling traceability rules mean a battery pack needs type approval and a traceable recycling channel. The 2024 revision of the *Measures for Comprehensive Utilisation of End-of-Life NEV Power Batteries* (effective 1 January 2025) raises the bar further: registered capital of no less than RMB 10 million, paid-in capital of no less than RMB 5 million,梯次利用 capacity of at least 1,000 t/year and再生利用 of at least 5,000 t/year. It lifts the lithium recovery rate from ≥85% to ≥90%, adds an electrode-powder recovery rate of ≥98% and impurity caps (aluminium <1.5%), and requires R&D spend as a share of utilisation revenue.

Traceability is the part most often underestimated. Every power battery receives a unique identification code and is tracked through a national platform from production to retirement; producers (including foreign battery makers) must register and meet recycling-responsibility obligations under the extended-producer-responsibility framework. Importers of complete vehicles with batteries should confirm the pack’s approval status and coding before shipment, because a non-compliant battery can block the whole vehicle’s type approval.

Localisation logic: from mandated ratio to market pull

With the ownership cap gone, a foreign battery firm is no longer required to form a JV or to source a fixed local share. In practice, however, China’s cell, material and equipment ecosystem is the densest in the world, so most entrants localise for cost and lead-time reasons. The driver has shifted: it is no longer a legal JV ratio but customer pull — Chinese OEMs (including foreign-brand JVs) now demand fast response, local R&D presence and ESG/sourcing credentials, and they increasingly award contracts to suppliers who can iterate on China’s 12–18 month development clock.

This matters for foreign Tier-1 battery and materials suppliers. A foreign cell maker that runs its China business on a slow headquarters cycle will lose bids not because it is expensive but because it is late. The 2026 competitive edge is local decision autonomy plus speed, not price alone.

Export barriers reshape the China play

Foreign battery firms in China must also plan for destination markets. The US 301 tariff review raised duties on Chinese EVs to 100% and on lithium batteries to 25% from 2024, and the US has layered software/hardware restrictions on connected and autonomous vehicles. The EU’s Battery Regulation (in force and tightening through 2026–2027) mandates carbon-footprint declarations, a digital battery passport, and minimum recycled-content thresholds; its CBAM indirectly raises the carbon cost of steel and aluminium enclosures. China’s own export-tax-rebate step-down on batteries (a rebate cut from 9% to 6% in 2026, with a planned further move) signals a push up the value chain.

The practical response for a foreign battery investor is to separate “China-for-China” from “China-for-export.” The former leans into the local supply chain and catalogue inclusion; the latter requires carbon-accounting, passport readiness and, for the US/EU, likely local production in those regions or routing through third countries with genuine transformation.

Where foreign capital can still win

Opportunities are not in commoditised cells but in high-value, capability-intensive segments:

  • Advanced materials and components — high-nickel cathodes, silicon-anode and separator/electrolyte formulations where foreign IP still leads.
  • Recycling and refurbishment — the 2024 norm and 2025 State Council action plan explicitly encourage producers to build recovery systems and use recycled metal; by early 2026 China had announced 148 compliant enterprises and clusters in Ganzhou and Changsha. Foreign players with hydrometallurgy or direct-recycling IP can partner locally.
  • Battery-swap and storage co-location — the 2026 halved NEV purchase tax and the separate energy-storage capacity-price mechanism (see the storage article) make pack-level services attractive.
  • Testing, certification and safety — SAMR-led national standards for recycling (22 published by late 2025) create demand for conformance and quality-infrastructure services.

Common pitfalls

  • Treating battery entry as pure manufacturing. Type approval, catalogue inclusion and traceability are separate gates; miss one and the pack cannot ship.
  • Assuming the JV cap removal removes local-content pressure. The pressure now comes from OEMs and ESG rules, not a legal ratio.
  • Underestimating recycling obligations. Extended-producer responsibility and the 90% lithium-recovery bar apply to foreign makers too.
  • Ignoring export carbon rules. EU passport/CBAM and US tariffs can erase China-cost advantages on outbound packs.
  • Running China on headquarters time. Slow decision cycles lose bids regardless of price.

What to do next

  • Confirm the MIIT catalogue and CCC path before committing a cell or pack line; budget for GB-standard testing and coding.
  • Build or partner for a compliant recycling/traceability channel — register on the national platform and meet the 2024 norm’s scale and recovery thresholds.
  • Localise materials and R&D decision-making in China to match the 12–18 month OEM clock; grant the China entity real autonomy.
  • Separate China-for-China from China-for-export; for the latter, stand up carbon accounting and passport readiness now.
  • Scout high-value niches (materials, recycling, swap/storage, testing) rather than competing on commoditised cells.
  • Track the 2025 Catalogue of Encouraged Foreign Investment Industries and local green-manufacturing incentives.

Sources

  • 工业和信息化部《新能源汽车废旧动力电池综合利用行业规范条件(2024年本)》解读(2025-01-01实施):https://policy.mofcom.gov.cn/claw/policyInfo.shtml?id=6971
  • 国家市场监督管理总局(SAMR)门户网站 — 动力电池回收利用国家标准:https://www.samr.gov.cn
  • 国家发展改革委(NDRC)门户网站 — 循环经济与绿色制造:https://www.ndrc.gov.cn
  • 科技日报 — 美国对华汽车产业关税措施相关报道(2026):https://www.stdaily.com/web/gjxw/2026-05/06/content_512332.html

Related reading

  • 新能源汽车整车制造准入(142-nev-manufacturing-2026)
  • 智能网联汽车(自动驾驶)外资测试牌照与数据合规(144-icv-2026)
  • 新型储能外资参与路径(149-storage-2026)

动力电池产业链:外资机会与本地化配套

概述

中国拥有全球最密集、成本最低的动力电池供应链——从正负极材料到电芯、电池包、BMS与回收。对国外电池企业与采购它们的OEM而言,该领域在法律上开放:电池制造无外资股比上限,2024年版负面清单整体清除了制造业限制。

2026年的实操问题不是”能否投资”,而是”在满足中国日益收紧的回收、溯源与技术规则的同时,如何在一个快速本地化的供应链上竞争,并在海外应对美欧贸易与碳壁垒”。本文勾勒监管底线、本地化逻辑,以及外资仍可胜出的位置。

监管底线:型式准入、目录与溯源

除一般制造准入外,电池另有一套制度。工信部”公告/目录”体系与电池回收溯源规则意味着,电池包须通过型式准入并具备可追溯回收渠道。2024年修订的《新能源汽车废旧动力电池综合利用行业规范条件(2024年本)》(2025年1月1日施行)进一步抬高门槛:注册资本不少于1000万元、实缴不少于500万元,梯次利用产能不低于1000吨/年、再生利用不低于5000吨/年;锂回收率由≥85%提至≥90%,新增电极粉料回收率≥98%与杂质上限(铝<1.5%),并要求研发费用占综合利用业务收入的比例。

溯源是最常被低估的一环。每块动力电池具唯一识别编码,经国家平台从生产追踪至退役;生产者(含外资电池企业)须登记并依生产者责任延伸框架履行回收义务。进口含电池整车者应在发运前确认电池包准入状态与编码,因为不合规电池可拖垮整车准入。

本地化逻辑:从强制比例到市场牵引

股比上限取消后,外资电池企业不再被强制组建合资或采购固定本地比例。但实践中,中国的电芯、材料与设备生态全球最密集,多数进入者为成本与交期而本地化。驱动力已转变:不再是法律上的合资比例,而是客户牵引——中国OEM(含外资品牌合资企业)如今要求快速响应、本地研发存在感与ESG/采购资质,并日益把合同授予能在中国12–18个月开发节奏上迭代的供应商。

这对国外电池与材料Tier-1至关重要。若以总部慢周期运营中国业务,丢单并非因为贵,而是因为慢。2026年的竞争优势是本地决策自主权加速度,而非仅靠价格。

出口壁垒重塑中国打法

在中国的外资电池企业还须规划目的地市场。美国301复审自2024年起将中国电动车关税提至100%、锂电池提至25%,并对智能网联与自动驾驶汽车叠加软件/硬件限制。欧盟新电池法(已生效并在2026–2027年趋严)要求碳足迹声明、数字电池护照与最低回收料比例;其CBAM通过钢铝外壳间接抬高碳成本。中国自身对电池出口退税的阶梯式下调(2026年由9%降至6%,并计划进一步退出)释放了向价值链上游迈进的信号。

对外资电池投资者的务实应对,是将”中国供中国”与”中国供出口”分开。前者依托本地供应链与目录列入;后者须具备碳核算、护照准备,且对美欧市场大概率需要在当地生产或经具备实质性转化的第三国绕道。

外资仍可胜出的位置

机会不在商品化电芯,而在高价值、能力密集的环节:

  • 先进材料与部件 —— 高镍正极、硅负极及隔膜/电解液配方,外资IP仍领先。
  • 回收与再利用 —— 2024年规范与2025年国务院行动方案明确鼓励生产者建立回收体系并使用再生金属;截至2026年初中国已公告148家合规企业,形成赣州、长沙集群。具备湿法冶金或直接回收IP的外资可本地合作。
  • 换电与储能协同 —— 2026年购置税减半与独立的储能容量电价机制(见储能篇)使包级服务具吸引力。
  • 测试、认证与安全 —— 市场监管总局主导的回收国标(2025年底已发布22项)催生对合规与质量基础设施服务的需求。

常见误读

  • 把电池进入当作纯制造。 型式准入、目录列入与溯源是分立闸门;漏掉一项电池包便无法出货。
  • 以为取消股比即消除本地含量压力。 压力如今来自OEM与ESG规则,而非法律比例。
  • 低估回收义务。 生产者责任延伸与90%锂回收门槛同样适用于外资企业。
  • 忽视出口碳规则。 欧盟护照/CBAM与美国关税可抹平中国成本优势。
  • 以总部节奏运营中国。 慢决策周期无论价格如何都会丢单。

下一步建议

  • 在落子电芯或电池包产线前,确认工信部目录与CCC路径;为GB标准测试与编码预留预算。
  • 建设或合作合规的回收/溯源渠道——在国家平台登记,并满足2024年规范的规模与回收门槛。
  • 在中国本地化材料与研发决策,以匹配12–18个月OEM节奏;赋予中国实体真实自主权。
  • 区分中国供中国与中国供出口;对后者,立即建立碳核算与护照准备。
  • 瞄准高价值利基(材料、回收、换电/储能、测试),而非在商品化电芯上竞争。
  • 关注2025年版《鼓励外商投资产业目录》与地方绿色制造激励。

来源

  • 工业和信息化部《新能源汽车废旧动力电池综合利用行业规范条件(2024年本)》解读(2025-01-01实施):https://policy.mofcom.gov.cn/claw/policyInfo.shtml?id=6971
  • 国家市场监督管理总局(SAMR)门户网站 — 动力电池回收利用国家标准:https://www.samr.gov.cn
  • 国家发展改革委(NDRC)门户网站 — 循环经济与绿色制造:https://www.ndrc.gov.cn
  • 科技日报 — 美国对华汽车产业关税措施相关报道(2026):https://www.stdaily.com/web/gjxw/2026-05/06/content_512332.html

相关阅读

  • 新能源汽车整车制造准入(142-nev-manufacturing-2026)
  • 智能网联汽车(自动驾驶)外资测试牌照与数据合规(144-icv-2026)
  • 新型储能外资参与路径(149-storage-2026)

Non-academic after-school training: 2026 foreign-investment boundary and compliance

  • Non-academic after-school training (sports, arts, science/technology) is permitted for foreign-invested operators in company form, but it remains “education” and requires a licence, registration and platform onboarding.
    非学科类校外培训(体育、艺术、科技)允许以外商投资企业(公司形式)运营,但其仍属”教育”,须取得许可、登记并接入监管平台。
  • Local 2026 rules (e.g., Dingxi, Taishan) define non-academic training as cultural-arts, sports and science/technology, with for-profit and non-profit classification and sector-specific approval.
    2026 年地方规则(如定西、台山)将非学科类界定为文化艺术、体育、科技类,实行营利/非营利分类与分行业审批。
  • Fee caps bind non-academic training too: generally no more than RMB 5,000 per collection and no more than 3 months or 60 class-hours, with pre-collected fees in a dedicated custodial account.
    收费上限同样约束非学科类:一般单次不超 5000 元、不超 3 个月或 60 课时,预收费进专用托管账户。
  • The “white list” mechanism (e.g., Taishan 2026) lets vetted non-academic institutions enter schools for after-class services, but with strict in-school time and commercial-promotion limits.
    “白名单”机制(如台山 2026)允许合规非学科机构入校提供课后服务,但有严格的在校时长与商业推广限制。
  • Foreign investors must respect the compulsory-education foreign-investment ban: a foreign-controlled K12 entity cannot run subject tutoring, and must not use non-academic cover for subject teaching.
    外资须尊重义务教育外资禁令:外资控制的 K12 主体不得开展学科类培训,也不得以非学科为壳从事学科教学。
  • The June 2026 foreign-investment Action Plan widens vocational training, not K12 after-school, so non-academic K12 remains a licensing/ compliance game rather than a new opening.
    2026 年 6 月外资行动方案拓宽的是职业培训而非 K12 课后培训,故非学科 K12 仍是许可/合规议题,而非新的开放。
  • Compliance pivots on the national supervision platform, content review, faculty qualifications and the “one class one settlement” fee rule.
    合规关键在于全国监管平台、内容审核、师资资质与”一课一消”收费规则。

Non-academic after-school training: 2026 foreign-investment boundary and compliance | 2026 非学科类校外培训:外资参与边界与合规

Overview

Non-academic after-school training — sports, arts, and science/technology (STEM) — is the segment of China’s tutoring market that sits just outside the “double reduction” subject-tutoring ban. It is permitted, it is growing, and it is where foreign brands and curricula most naturally fit. But “non-academic” is not “unregulated”: in 2026 it remains firmly within the off-campus-training regulatory regime, requiring a licence, business registration, national-platform onboarding, fee custody and content review. For a foreign investor the question is not whether the segment is open — it is how to enter without tripping the subject-tutoring red line or the compulsory-education foreign-investment ban.

This article maps the 2026 boundary, the local rules now in force, the “white list” school-entry route, and a compliance checklist.

What “non-academic” covers in 2026

Local 2026 rule-making is consistent. Dingxi (Gansu) published, on 27 January 2026, draft *Measures for the Approval and Administration of Non-Academic Off-Campus Training Institutions*, defining the scope as cultural-arts (music, art, dance, calligraphy, drama, quyi), science/technology (coding, robotics), and sports — activities that aid quality development for preschool children and school students. The draft expressly excludes sports clubs, vocational-certification and life-skills training, and applies the national off-campus rules to online training. Taishan (Guangdong), in a 18 March 2026 notice, opened a “white list” for non-academic institutions to enter school after-class services, covering science/technology, cultural-arts, sports and comprehensive-practice categories, requiring both the *Private School Operating Licence* and business registration, plus onboarding onto the national supervision platform with fund custody.

The recurring requirements across jurisdictions are: (1) separate approval by the relevant sector authority (sport, culture-tourism, science-technology); (2) a site/safety review; (3) the operating licence and market registration; (4) inclusion in the unified off-campus platform; and (5) operation strictly within the approved scope — no subject tutoring.

Fee, content and personnel rules

Non-academic training is bound by the same consumer-protection core as the rest of the sector:

  • Fee caps: pre-collected fees generally may not exceed RMB 5,000 per single collection and no more than 3 months or 60 class-hours; funds enter a dedicated account separate from the institution’s own funds.
  • Content review: training materials must be politically correct and age-appropriate, free of advance-over-standard content, commercial advertising, or religious/pornographic/violent material; non-academic materials use an internal-review responsibility system with filing and random checks.
  • Personnel: staff must pass background checks (no records of sexual assault, abuse, trafficking, violence); teachers need the relevant professional-capability certificate or teacher qualification; all personnel are managed on the national platform.
  • Advertising: no off-campus training ads to minors on mainstream media or online/offline public spaces; no preschool online-training ads.

The “white list” school-entry route

A distinctive 2026 feature is the “white list” mechanism letting vetted non-academic institutions deliver after-class services inside public schools. Taishan’s rules illustrate the model: schools run a second-round selection from the district “white list”, sign a service agreement, and may not let the institution exceed one-third of the week’s after-class service time; fees must be below market and funds in a bank-custody account; in-school staff must follow teacher-ethics rules and may not do commercial promotion, recruit students, or teach subjects. A blacklist/exit system applies for false qualifications, safety incidents, service-quality failure, or satisfaction below 80%.

For a foreign-invested brand this is doubly relevant: it is a channel to reach students at scale through schools, but it demands strict separation from subject content and tight compliance with the platform and fee rules.

The foreign-investment boundary

Two prohibitions frame the foreign boundary:

  1. Compulsory-education foreign-investment ban: the foreign-investment negative list and the private-education framework keep compulsory education off-limits to foreign-controlled schools. A foreign-invested company may operate non-academic training in company form, but it cannot use that vehicle to deliver subject tutoring or run a compulsory-education school.
  2. No “cover” for subject teaching: regulators explicitly target institutions that use non-academic licences to run disguised subject tutoring (e.g., “thinking training”, “national studies”, “cram classes”). The 2026 holiday notices repeatedly warn against such cross-line behaviour.

The June 2026 *Action Plan for Stabilising and Optimising Foreign Investment* opens vocational training and certain higher-education pilots — not K12 after-school. So non-academic K12 remains a licensing and compliance exercise, not a newly liberalised entry point for foreign capital.

Compliance checklist for foreign investors

  • Form and licence: establish a PRC company (WFOE or JV) for the training entity; obtain the operating licence from the competent education/sport/culture/science authority and complete market registration.
  • Scope discipline: register clearly as cultural-arts / sports / science-technology; never drift into subject content; train staff to recognise and avoid disguised-subject formats.
  • Platform and custody: onboard the national supervision platform; route all pre-collected fees to custodial accounts; adopt “one class one settlement” and the RMB 5,000 / 3-month / 60-class-hour caps.
  • Content and personnel: implement internal material review with filing; run background checks; verify teacher qualifications; manage everyone on the platform.
  • School-entry caution: if pursuing the white-list route, accept the one-third time cap, fee-below-market and no-promotion constraints, and build service-quality tracking to avoid blacklisting.
  • Negative-list screen: confirm the entity is non-academic and outside compulsory-education control before investing; keep a Chinese partner where cooperation is required.

Sources

Related reading

  • see also: Vocational training and education opening for foreign investors (article 138)
  • see also: Online education and EdTech regulation for foreign investors (article 139)
  • see also: Corporate training market for foreign and China-based employees (article 141)

2026 非学科类校外培训:外资参与边界与合规

概述

非学科类校外培训——体育、艺术、科技(STEM)——处于中国培训市场中刚好在”双减”学科类禁令之外的segment。它被允许、在增长,也最契合外资品牌与课程。但”非学科”不等于”无监管”:2026 年它仍牢牢处在校外培训监管体系内,须取得许可、商事登记、接入全国平台、收费托管与内容审核。对外资而言,问题不在segment是否开放,而在于如何进入而不触碰学科类红线或义务教育外资禁令。

本文梳理 2026 年边界、现行地方规则、”白名单”入校路径与合规清单。

2026 年”非学科”的界定

2026 年地方立法口径一致。甘肃定西 2026 年 1 月 27 日发布《非学科类校外培训机构审批及管理办法(征求意见稿)》,将范围界定为文化艺术(音乐、美术、舞蹈、书法、戏曲戏剧、曲艺)、科技(编程、机器人)、体育——有助于学前儿童与中小学生素质提升的活动;明确排除体育俱乐部、职业资格认证、生活技能训练,并对线上培训适用全国规则。广东台山 2026 年 3 月 18 日通告开放非学科机构入校课后服务”白名单”,覆盖科技、文化艺术、体育、综合实践类,要求同时持有《民办学校办学许可证》与营业执照,并接入全国监管平台、实行资金监管。

各地共性要求为:(1)经对应行业主管部门(体育、文旅、科技)审核;(2)场地/安全审核;(3)办学许可与市场主体登记;(4)纳入统一校外平台;(5)严格在审批范围内经营——不得学科类培训。

收费、内容与人员规则

非学科类受与全行业相同的消费者保护核心约束:

  • 收费上限: 预收费一般单次不超 5000 元、不超 3 个月或 60 课时;资金进入与自有资金分账的专用账户。
  • 内容审核: 培训材料须政治导向正确、适龄,不得超标超前、含商业广告或宗教/色情/暴力内容;非学科材料实行机构内部审核责任制,备案并事后抽查。
  • 人员: 从业人员须通过准入查询(无性侵、虐待、拐卖、暴力等记录);教师须具相应专业能力证明或教师资格;全员纳入全国平台管理。
  • 广告: 不得向未成年人投放校外培训广告;不得发布学前线上培训广告。

“白名单”入校路径

2026 年的一个鲜明特征是”白名单”机制,允许合规非学科机构入校提供课后服务。台山规则示范了该模式:学校从区级”白名单”二次遴选、签服务协议,机构进校服务周累计时长原则上不超本周课后服务总时长三分之一;收费须低于市场价、资金进银行监管账户;进校人员须守师德师风,不得商业推广、招生或学科教学;对虚假资质、安全责任事故、服务质量不达标或满意度低于 80% 等情形设黑名单/退出机制。

对外资品牌,此路径双重相关:既是通过学校规模化触达学生的渠道,又要求与学科内容严格隔离,并紧密遵守平台与收费规则。

外资参与边界

两道禁令框定外资边界:

  1. 义务教育外资禁令: 外资负面清单与民办教育框架将义务教育排除在外资控制的学校之外。外商独资企业可以公司形式运营非学科培训,但不得借此开展学科类培训或举办义务教育学校。
  2. 不得以非学科为壳: 监管明确打击以非学科许可开展隐形学科培训(如”思维训练””国学””补习班”)。2026 年假期告知书反复警示此类越线行为。

2026 年 6 月《利用外资固稳促优行动方案》开放的是职业培训与部分高教试点,而非 K12 课后培训。因此非学科 K12 仍是许可与合规议题,而非外资新开放的入口。

外资合规清单

  • 形式与许可: 为培训机构设立境内公司(WFOE 或合资);向教育/体育/文旅/科技主管部门取得办学许可并完成商事登记。
  • 范围纪律: 明确登记为文化艺术/体育/科技类;绝不滑向学科内容;培训员工识别并规避隐形学科形式。
  • 平台与托管: 接入全国监管平台;预收费全进托管账户;实行”一课一消”及 5000 元/3 个月/60 课时上限。
  • 内容与人员: 建立材料内部审核与备案;背景查询;核验师资资格;全员平台管理。
  • 入校审慎: 若走白名单,接受三分之一时长上限、低于市场价与禁推广约束,并建立服务质量跟踪以防黑名单。
  • 负面清单筛查: 投资前确认主体为非学科且在义务教育控制之外;需合作时保留中方伙伴。

来源

相关阅读

  • 见:外商投资职业教育与职业技能培训(第 138 篇)
  • 见:外资在线教育/EdTech 监管现状(第 139 篇)
  • 见:面向外资企业的员工培训服务市场(第 141 篇)

Segmented Pharmaceutical Production in China: A New Manufacturing Option for Foreign MAHs

  • On 15 May 2026 the revised Implementation Regulations of the Drug Administration Law took effect, with Article 32 expressly allowing segmented (split-site) production of qualifying innovative drugs under a unified quality-assurance system.
    2026年5月15日,新修订的《药品管理法实施条例》施行,其中第三十二条明确允许符合条件的创新药在统一质量保证体系下分段委托生产。
  • The State Drug Administration has separately worked on biological-product segmented production; the 2026 Action Plan to Stabilise and Optimise Foreign Investment now calls for detailed rules for cross-border segmented production of both biologicals and chemical drugs.
    国家药监局已就生物制品分段生产单独发文推进;2026年《利用外资固稳促优行动方案》进一步提出研究出台药品分段生产实施细则,便利境外药品上市许可持有人开展生物制品、化学药品跨境分段生产。
  • Segmented production applies to innovative drugs with special production-process or facility requirements, clinically urgent drugs, and drugs needed for public-health emergencies, as designated by the State Council.
    分段生产适用于生产工艺、设施设备有特殊要求的创新药,临床急需的药品,以及突发公共卫生事件急需或储备需要的药品等国务院规定情形。
  • The marketing authorisation holder (MAH) remains the single, final quality-responsible party and must build a unified quality-assurance system spanning all production sites.
    药品上市许可持有人(MAH)仍是唯一、最终的质量责任主体,必须建立覆盖药品生产全过程和全部生产场地的统一质量保证体系。
  • For foreign MAHs, the combination of segmented production and the FIE action plan opens a path to structure cross-border biologics and chemical manufacturing while keeping Chinese regulatory responsibility centralised.
    对外资MAH而言,分段生产与稳外资行动方案的组合,为跨境生物制品与化学药品生产布局开辟了路径,同时保持中国监管责任集中化。
  • Commercial insurers are also being encouraged to cover more innovative drugs and devices, and foreign-made drugs gain smoother entry into retail channels.
    政策同时鼓励保险公司将更多创新药械纳入商业保险保障范围,并便利外资企业生产的药品进入药品零售渠道。

Segmented Pharmaceutical Production in China: A New Manufacturing Option for Foreign MAHs | 中国药品分段生产:外资上市许可持有人的制造新选项

Why this matters now

Pharmaceutical manufacturing has traditionally meant one site, one product, one end-to-end process. China’s 2026 regulatory wave is deliberately unpicking that assumption. On 15 May 2026, the revised Implementation Regulations of the Drug Administration Law took effect, and Article 32 explicitly permits the segmented production of qualifying innovative drugs — where manufacturing steps run at different sites and potentially through different companies — as long as the marketing authorisation holder maintains a unified quality-assurance system. The move is paired with an explicit signal to foreign investors: the June 2026 Action Plan to Stabilise and Optimise Foreign Investment (issued by MOFCOM, NDRC and MOF) commits to detailed rules for cross-border segmented production of biological products and chemical drugs, building on the earlier biological-product segmented-production pilot. For a global pharma company with an approved innovative molecule, this changes how production for the Chinese market can be structured.

What segmented production covers

Article 32 of the revised Implementation Regulations permits segmented production for three categories: innovative drugs whose production process, equipment or facilities have special requirements; clinically urgent drugs requested by relevant State Council departments; and drugs needed for emergency response or stockpiling. The MAH may commission qualified production enterprises to handle separate production steps. Critically, the law does not decentralise responsibility: the MAH must establish a unified quality-assurance system covering the entire production process and all production sites, and remains the single final responsible party for product quality. The State Drug Administration’s inspection guidance for biological-product segmented production further requires the MAH to align quality-management systems across segment producers, apply quality-risk management to contamination and cross-contamination risks, and ensure the quality authorisation holder can base final release decisions on a full review of data from all segments.

The foreign-investment angle

The FIE Action Plan published in June 2026 explicitly says the authorities will move quickly to issue implementation rules for segmented production, to facilitate overseas drug marketing authorisation holders in carrying out cross-border segmented production of biologicals and chemical drugs. This is the first time the policy explicitly opens the door to cross-border arrangements — a Chinese plant handling one production step, an overseas site another. For foreign MAHs, the practical attraction is manufacturing flexibility: an API or biologic intermediate can be produced at the site with the best economics and IP-protection profile, with final formulation and packaging in China, while quality oversight remains anchored in one unified system. The same plan adds supporting measures: expanding the pilot scope for biotechnology and wholly foreign-owned hospitals, encouraging commercial insurers to cover more innovative drugs and devices, and easing foreign-made drugs into retail pharmacy channels.

Practical steps for foreign MAHs

  1. Map your portfolio. Identify molecules that qualify for segmented production — innovative drugs with special process or facility needs, clinically urgent products, or emergency/stockpile candidates.
  2. Decide the China anchor. Choose which production step will be performed in China and by which qualified manufacturer, and where the MAH quality-authorisation function will sit.
  3. Design the unified quality system. Draft the single quality-assurance framework covering all sites and segments, including technology transfer, change control, deviation handling and CAPA procedures.
  4. Engage the SDA early. Because implementation rules for chemical cross-border segmented production are still being drafted, use pre-submission consultation channels to align on expectations before committing investment.
  5. Review supply-chain economics. Model the tax, customs and logistics treatment of intermediates moving across borders, including bonded and duty-free options where available.
  6. Coordinate with insurance and retail access. Plan for how the product will reach patients — commercial insurance coverage and retail channel entry both affect market-access planning.

Risks and compliance notes

Segmented production is a permission, not a relaxation. The MAH’s single-responsibility rule means a failure at any segment is ultimately the MAH’s failure; contract manufacturers’ systems must be auditable and aligned. Foreign MAHs should also track the still-evolving implementation rules for chemical cross-border segmented production — until they issue, cross-border arrangements for small-molecule drugs should be structured conservatively. IP protection of process know-how across borders, GMP consistency between sites, and batch-release responsibilities all need contractual precision. Finally, the SDA’s on-site inspection and post-market supervision powers are unchanged, so documentation and traceability must satisfy the same standards as single-site production.


中国药品分段生产:外资上市许可持有人的制造新选项

为什么当下重要

药品生产传统上意味着”一个场地、一个产品、一条端到端流程”。中国2026年的监管浪潮正有意拆解这一假设。2026年5月15日,新修订的《药品管理法实施条例》施行,第三十二条明确允许符合条件的创新药分段生产——即制造环节在不同场地、甚至经由不同公司运行——只要上市许可持有人维护统一质量保证体系。该举措与对外资投资者的明确信号相配合:2026年6月商务部、国家发展改革委、财政部发布的《利用外资固稳促优行动方案》承诺研究出台生物制品与化学药品跨境分段生产实施细则,在早期生物制品分段生产试点基础上推进。对拥有获批创新分子的全球制药企业而言,这改变了中国市场的生产布局方式。

分段生产覆盖哪些情形

修订后《实施条例》第三十二条允许三类药品分段生产:生产工艺、设施设备有特殊要求的创新药;国务院有关部门提出的临床急需药品;以及应对突发公共卫生事件急需或储备需要的药品。MAH可以委托符合条件的生产企业承担不同生产步骤。关键在于,法律并未分散责任:MAH必须建立覆盖药品生产全过程和全部生产场地的统一质量保证体系,并作为产品质量唯一且最终的责任主体。国家药监局生物制品分段生产现场检查指南进一步要求MAH使各分段生产企业的质量管理体系有效衔接与统一,运用质量风险管理方法识别控制污染、交叉污染及差错风险,并确保质量受权人能基于对各分段数据的全面审核作出最终放行决定。

外资维度

2026年6月发布的稳外资行动方案明确提出,抓紧研究出台药品分段生产实施细则,便利境外药品上市许可持有人开展生物制品、化学药品跨境分段生产。这是政策首次明确为跨境安排敞开大门——中国工厂承担一个生产步骤,海外场地承担另一个。对外资MAH而言,实际吸引力在于制造灵活性:原料药或生物制品中间体可在经济性与知识产权保护最优的场地生产,最终制剂与包装放在中国,而质量监督仍锚定于一个统一体系。同一方案还附带了配套措施:扩大生物技术、外商独资医院开放试点区域范围,支持保险公司将更多创新药械纳入商业保险,并便利外资企业生产的药品进入零售药店渠道。

外资MAH的操作步骤

  1. 梳理产品组合。 识别符合分段生产条件的分子——生产工艺或设施有特殊要求的创新药、临床急需产品或应急/储备候选品。
  2. 确定中国锚点。 选择哪个生产步骤在中国、由哪家合格生产商执行,以及MAH质量受权职能设在何处。
  3. 设计统一质量体系。 起草覆盖全部场地与分段的单一质量保证框架,包括技术转移、变更控制、偏差处理与CAPA程序。
  4. 尽早与国家药监局沟通。 由于化学药品跨境分段生产实施细则仍在起草中,在投入投资前应利用预沟通渠道对齐预期。
  5. 审查供应链经济性。 建模中间体跨境流动的税收、海关与物流处理,在可行时考虑保税与免税选项。
  6. 协同保险与零售准入。 规划产品如何触达患者——商业保险覆盖与零售渠道进入都影响市场准入规划。

风险与合规提示

分段生产是许可,不是放松。MAH单一责任规则意味着任何分段的失败最终都是MAH的失败;合同生产商的体系必须可审计、可对齐。外资MAH还应跟踪仍在制定的化学药品跨境分段生产实施细则——在细则出台前,小分子药物跨境安排应保守设计。跨境工艺know-how的知识产权保护、场地间GMP一致性、批次放行责任都需要合同上的精确性。最后,药监局现场检查与上市后监管权限不变,因此文档与可追溯性必须满足与单一场地生产相同的标准。

Sources

  • 商务部 国家发展改革委 财政部《利用外资固稳促优行动方案》(商资发〔2026〕97号)——第三条”支持外资参与医药等产业高质量发展”(研究出台药品分段生产实施细则、便利境外MAH跨境分段生产):https://sxdofcom.shaanxi.gov.cn/fdi/yhzc/40265.jhtml
  • 商务部副部长凌激出席国新办发布会介绍利用外资固稳促优有关政策措施(王亚回应医药开放措施,生物制品分段生产试点、化学药品跨境分段生产细则):https://swj.wulanchabu.gov.cn/zxft/1994919.html
  • 中国医药创新促进会《药品管理法实施条例大家谈 在鼓励创新与严守底线间找到平衡》(第三十二条分段生产、MAH统一质量保证体系解读):https://www.phirda.com/artilce_43447.html
  • 山西省民营经济发展局官网《外资企业可重点关注哪些扩大准入领域?》(2026-08-10,摘自商资发〔2026〕97号:药品分段生产、生物技术和外商独资医院领域扩大开放):https://myj.shanxi.gov.cn/ztzl/bwbd/lywzgw/202608/t20260810_10196322.shtml